UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM
_________________
(Mark One)
For the quarterly period ended:
For the transition period from
Commission
File Number:
_____________________
(Exact name of registrant as specified in its charter)
_____________________
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
| 91942 | ||
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
N/A
(Former name or former address and former fiscal year, if changed since last report)
_________________
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ | Accelerated filer ☐ |
| Smaller reporting company | |
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes ☐
APPLICABLE ONLY TO CORPORATE ISSUERS
As of September 30, 2023 there were shares of common stock issued and outstanding.
| 1 |
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
| SYBLEU INC. | ||||||||
| CONDENSED BALANCE SHEETS | ||||||||
As of September 30, 2023 | As of June 30, 2023 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| CURRENT ASSETS | ||||||||
| Cash | $ | $ | ||||||
| Prepaid Expenses | ||||||||
| Total Current Assets | $ | $ | ||||||
| OTHER ASSETS | ||||||||
| Investment Securities | ||||||||
| Prepaid Expenses ( Long Term) | ||||||||
| Acquired Intangible Assets, net of amortization | ||||||||
| Total Other Assets | ||||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Income Taxes Payable | ||||||||
| Notes Payable | ||||||||
| Notes Payable, Related Party | ||||||||
| Expenses Accrued but Unpaid | ||||||||
| Interest Accrued but Unpaid | ||||||||
| Total Current Liabilities | ||||||||
| Long Term Liabilities: | ||||||||
| Unearned Income | ||||||||
| Note Payable | ||||||||
| Total Liabilities | $ | $ | ||||||
| STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||
| Common Stock ($.0001 par value) shares authorized; par value $; shares issued and outstanding as of September 30, 2023 and shares issued and outstanding as of June 30, 2023 | ||||||||
| Additional Paid in capital | ||||||||
| Common Stock Payable | ||||||||
| Contributed Capital | ||||||||
| Retained Earnings (Deficit) | ( | ) | ( | ) | ||||
| Total Stockholders' Equity (Deficit) | ( | ) | ( | ) | ||||
| TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT) | $ | $ | ||||||
| The Accompanying Notes are an Integral Part of These Financial Statements | ||||||||
| 2 |
| SYBLEU INC. | ||||||||
| CONDENSED STATEMENT OF OPERATIONS | ||||||||
| (Unaudited) | ||||||||
| Quarter Ended September 30, 2023 | Quarter Ended September 30, 2022 | |||||||
| REVENUES | ||||||||
| License Fees | ||||||||
| TOTAL REVENUES | $ | $ | ||||||
| COSTS AND EXPENSES | ||||||||
| Research and Development: | ||||||||
| Staff Expenses | ||||||||
| Consulting Costs | ||||||||
| Licensing Expenses | ||||||||
| Patent Application Costs | ||||||||
| Intellectual Property Acquisition Costs | ||||||||
| Total Research and Development | ||||||||
| General and Administrative: | ||||||||
| Transfer Agency Fees | ||||||||
| Other General and Administrative Expenses | ||||||||
| Total General and Administrative | ||||||||
| Consulting, Related Party | ||||||||
| Consulting: | ||||||||
| Legal Fees | ||||||||
| Accounting | ||||||||
| Other Consulting | ||||||||
| Website Development | ||||||||
| Information Technology Consulting | ||||||||
| Securities Depository Consulting | ||||||||
| Total Consulting | ||||||||
| Rent | ||||||||
| Total Costs and Expenses | ||||||||
| OPERATING Income( LOSS) | $ | ( | ) | $ | ( | ) | ||
| OTHER INCOME AND EXPENSES | ||||||||
| Unrealized Gain (Loss) on Investment Securities | ( | ) | ( | ) | ||||
| Stock Cancellation Expense | ||||||||
| Interest Income (Expense) | ( | ) | ( | ) | ||||
| Amortization of Acquired Intangible Assets | ( | ) | ||||||
| TOTAL OTHER INCOME (EXPENSES) | ( | ) | ( | ) | ||||
| NET INCOME ( LOSS) before taxes | ( | ) | ( | ) | ||||
| Provision for Income Taxes | ||||||||
| NET INCOME ( LOSS) | $ | ( | ) | $ | ( | ) | ||
| BASIC AND FULLY DILUTED LOSS PER SHARE | $ | ( | ) | $ | ||||
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING | ||||||||
| The Accompanying Notes are an Integral Part of These Financial Statements | ||||||||
| 3 |
| SYBLEU INC. | ||||||||||||||||||||||||||||
| CONDENSED STATEMENTS OF SHAREHOLDERS EQUITY (DEFICIT) | ||||||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||||
| For the Quarter Ended September 30, 2022 | ||||||||||||||||||||||||||||
| Common | ||||||||||||||||||||||||||||
| Shares | Amount | Additional Paid in Capital | Retained Deficit | Contributed Capital | Common Stock Payable | Total | ||||||||||||||||||||||
| Balance June 30, 2022 | $ | $ | $ | ( | ) | $ | $ | $ | ( | ) | ||||||||||||||||||
| Net Loss for the quarter ended September 30, 2022 | ( | ) | ( | ) | ||||||||||||||||||||||||
| Balance September 30, 2022 | $ | $ | $ | ( | ) | $ | $ | $ | ( | ) | ||||||||||||||||||
| For the Quarter Ended September 30, 2023 | ||||||||||||||||||||||||||||
| Common | ||||||||||||||||||||||||||||
| Shares | Amount | Additional Paid in Capital | Retained Deficit | Contributed Capital | Common Stock Payable | Total | ||||||||||||||||||||||
| Balance June 30, 2023 | $ | $ | $ | ( | ) | $ | $ | $ | ( | ) | ||||||||||||||||||
| Net Loss for the three months ended September 30, 2023 | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||||
| Capital Contributions during the three months ended September 30, 2023 | $ | $ | ||||||||||||||||||||||||||
| Additions (Subtractions) Common Stock Payable three months ended September 30, 2023 | $ | $ | ||||||||||||||||||||||||||
| Balance September 30, 2023 | $ | $ | $ | ( | ) | $ | $ | $ | ( | ) | ||||||||||||||||||
| The Accompanying Notes are an Integral Part of These Financial Statements | ||||||||||||||||||||||||||||
| 4 |
| SYBLEU INC. | ||||||||||||||||||||
| CONDENSED STATEMENT OF SHAREHOLDERS EQUITY (DEFICIT) | ||||||||||||||||||||
| For the Nine Months ended March 31,2022 | ||||||||||||||||||||
| (unaudited) | ||||||||||||||||||||
| Common | ||||||||||||||||||||
| Shares | Amount | Additional Paid in Capital | Retained Deficit | Total | ||||||||||||||||
| Balance June 30, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
| Net Loss for the three months ended September 30,2021 | - | ( | ) | $ | ( | ) | ||||||||||||||
| Balance September 30,2021 | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
| Net Loss for the three months ended December 31,2021 | - | $ | ( | ) | $ | ( | ) | |||||||||||||
| Balance December 31, 2021 | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
| Net Loss for the three months ended March 31, 2022 | - | $ | ( | ) | $ | ( | ) | |||||||||||||
| Balance March 31, 2022 | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||
| The Accompanying Notes are an Integral Part of These Financial Statements | ||||||||||||||||||||
| 5 |
| SYBLEU INC. | ||||||||
| CONDENSED STATEMENT OF CASH FLOWS | ||||||||
| (Unaudited) | ||||||||
| Quarter ended September 30, 2023 | Quarter ended September 30, 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | $ | (145,639 | ) | $ | (19,750 | ) | ||
| Net Income (Loss) | ||||||||
| Adjustments to reconcile net Income (loss) to net cash | ||||||||
| Common Stock Issued for payment of expenses | ||||||||
| Changes in Operating Assets and Liabilities | ||||||||
| (Increase) Decrease in Prepaid Expenses | ||||||||
| Increase (Decrease) in Accrued Expenses | ||||||||
| (Increase) Decrease in Securities accepted as Payment | ||||||||
| Increase( Decrease) in Unearned Income | ( | ) | ( | ) | ||||
| Increase ( Decrease) in Income Tax Payable | ||||||||
| Decrease in Common Stock | ||||||||
| Decrease in Additional Paid in Capital | ||||||||
| Unrealized Loss (Gain) in Investment Securities | ||||||||
| Increase in Common Stock Payable | ||||||||
| Increase in Amortization of Acquired Intangible Assets | ||||||||
| Increase in Capital Contributions | ||||||||
| Net Cash provided by (used) in Operating Activities | $ | ( | ) | $ | ( | ) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Increase (Decrease) in Notes Payable, Related Parties | ||||||||
| Increase (Decrease) in Notes Payable | ||||||||
| Common Stock issued for Cash | ||||||||
| Net Cash provided by (used) in Financing Activities | ||||||||
| Net Increase (Decrease) in Cash | $ | ( | ) | $ | ( | ) | ||
| Cash at Beginning of Period | ||||||||
| Cash at End of Period | $ | $ | ||||||
| Supplemental Cash Flow Information: | ||||||||
| Interest Paid | $ | $ | ||||||
| Income Taxes Paid | $ | $ | ||||||
| The Accompanying Notes are an Integral Part of These Financial Statements | ||||||||
| 6 |
SYBLEU INC.
Notes to Condensed Financial Statements
As of September 30, 2023
NOTE 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SYBLEU INC. (“Company”) was organized June 12, 2020 under the laws of the State of Wyoming.
The Company intends to engage primarily in the acquisition, licensing and development of regenerative medical applications up to the point of successful completion of Phase I and or Phase II clinical trials after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials. The primary factor to be considered by us in arriving at a decision to advance an application further to Phase III clinical trials would be a greater than anticipated indication of efficacy seen in Phase I trials.
A. BASIS OF ACCOUNTING
The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted a June 30 year-end.
B. USE OF ESTIMATES
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
C. CASH EQUIVALENTS
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.
D. FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:
Level 1: Quoted prices in active markets for identical assets or liabilities
Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
| 7 |
E. RESEARCH AND DEVELOPMENT COSTS
Research and development expenses relate primarily to the cost of discovery and research programs. Research and development costs are charged to expense as incurred. Research and development expenses consist mainly of evaluating potential Contract Research Organizations and filing of a provisional patent application.
Stock issued for Employee Compensation
Stock based compensation to employees is accounted for at the award’s fair value at grant, less the amount (if any) paid by the award recipient.
During the quarter ended September 30, 2023 stock was issued for Employee Compensation.
Stock issued for Non-Employee Services
Stock Based compensation to non-employees is accounted for in accordance with ASC 505-50. ASC 505-50 requires entities to account for non-employee equity transactions based on either the fair value of the services received or the fair value of the equity instrument issued utilizing whichever measurement is most reliable
During the quarter ended December 31, 2022 stock was issued for Non-Employee Services .
Pursuant to ASC 505-50-30-11505-50-30-11 an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date:
| i. | The date at which a commitment for performance by the counterparty to earn the equity instruments is reached (a performance commitment); and |
| ii. | The date at which the counterparty’s performance is complete. |
| 8 |
G. INCOME TAXES
The Company accounts for income taxes using the liability method prescribed by ASC 740, “Income Taxes.” Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.
The
Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides
clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements.
Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the
statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any
such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in
part, upon the results of operations for the given period. As of June 30, 2023 the Company had
The Company generated a deferred tax credit through net operating loss carry forward. However, a valuation allowance of 100% has been established.
Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19.
The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception.
Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. There were no Common Stock Equivalents as of June 30, 2023.
I. INTANGIBLE ASSETS
The Company amortizes its intangible assets with definite useful lives over their estimated useful lives and reviews these assets for impairment. The Company’s acquired intangible assets with definite useful lives consists of a 50% interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to (a) the intellectual property disclosed in US Patent US11377442B2 (Small molecule agonists and antagonists of NR2F6 activity) and (b) ) the intellectual property disclosed in US Patent US US10472351B2 (Small molecule agonists and antagonists of NR2F6 activity in animals).
NOTE 2. RECENT ACCOUNTING PRONOUNCEMENTS
The Company has adopted Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606). The guidance in this Update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification.
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. The Company has adopted the provisions of this ASU effective the fiscal year ended 2020. This guidance did not have a material impact on the Company’s Financial Statements.
On February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842). The ASU requires organizations that lease assets, referred to as “lessees,” to recognize on the consolidated statement of financial position the rights and obligations created by those leases. The ASU also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. These disclosures include qualitative and quantitative requirements, providing additional information about the amounts recorded in the consolidated financial statements. The ASU on leases became effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This guidance is not expected to have a material impact on the Company’s financial statements.
| 9 |
In June 2018, the FASB issued ASU No. 2018-07, Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with the accounting for employee share-based compensation. This ASU is effective for annual periods beginning after December 15, 2018 and interim periods within those annual periods, with early adoption permitted. This guidance is not expected to have a material impact on the Company’s financial statements.
NOTE 3. GOING CONCERN
The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has
generated net losses of $
Management plans to raise additional funds by offering securities for cash. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings.
NOTE 4. RELATED PARTY TRANSACTIONS.
The Company utilizes approximately 500 square feet of office space at 1034 Throggs Neck Expressway, Bronx NY 10465 provided to the Company by Joseph G. Vaini, the Company’s sole officer and director, on a month to month basis free of charge. The property is utilized as office space. We believe that the foregoing properties are adequate to meet our current needs for office space.
On
January 8, 2023 the Company entered into an agreement with Joanne Vaini whereby Joanne Vaini agreed to provide bookkeeping services for
the Company for the period beginning January 9, 2023 and ending July 9, 2024 (“Agreement”) for total consideration consisting
of $
On June 26, 2023 the Company was granted an exclusive worldwide license by DYO Biotechnologies, Pty, Ltd (“DYO”) to (a) to make, have made, use, offer for sale, sell, perform, have performed export and import Licensed Products and Licensed Services; (b) to practice Licensed Methods; and (c) to use Technology, all in the Field, within the Territory and during the Term (the “License”).
“Technology” is defined in the License
as” Artificial intelligence/machine learning engine designed to utilize existing chemical library structures in an integrated model
to predict highly specific and sensitive novel chemical structures for molecular targets.”
“Licensed Products” are defined in the License as “any product, kit, composition, or part thereof: (a) that incorporates,
uses, or is enabled or derived from the use of the Technology; or (b) that is produced or enabled by a Licensed Method.”
“Licensed Services” are defined in the License as “any service performed by Company or Sublicensee for the benefit of a third party that, in whole or in part, (a) uses Technology; (b) uses Licensed Product(s); or (c) that practices or is enabled by a Licensed Method.”
“Licensed Method” is defined in the License as “any method or process that uses Technology”
“Field” is defined in the License as small molecule drug development and commercialization for human and/or animal health.
“Territory” is defined in the License as “worldwide”.
The Term of the License is the period of time beginning on the effective date of this Agreement which shall be June 26, 2023 and terminating on the last to expire Royalty Term.
| 10 |
“Royalty Term” is defined in the License as that period of time beginning on the first commercial sale of a Licensed Product in a given country and, expires on a country-by-country basis with respect to each Licensed Product, upon the later of: (a) the expiration, abandonment, or invalidation of the last to expire, abandoned or invalidated Valid Claim of the Patent Rights in such country; (b) the expiration of any granted statutory period of marketing exclusivity within a country; and (c) 12 years from of the date of the first commercial sale of such Licensed Product in such country.
Pursuant to the terms and conditions of the License the Company shall raise $2,000,000 US through either debt or equity financing within 2 years of execution of this Agreement (“Funding”). The Company shall enter into a research collaboration agreement with DYO upon mutually acceptable terms and conditions within 30 days of Funding (“Research Agreement).
Substantially all of the Funding shall be utilized to enable the Technology for the benefit of developing Company’s existing and future small molecule drug intellectual property. It is anticipated that this research agreement will utilize substantially all of these funds over two years. It is agreed that the Company shall exclusively possess all right, title and interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to any and all inventions, discoveries, intellectual property and chemical structures resulting from this Research Agreement.
Pursuant to the terms and conditions of the License the Company shall pay to DYO a Royalty equal to five percent (5%) of the Net Sales ( as such term is defined in the License) of any Licensed Method, Service or Product per annum. The License also imposes an obligation upon the Company to make minimum royalty payments to DYO over the course of the Term.
Pursuant to the terms and conditions of the License
the l Company paid to DYO common shares of the Company (“Stock Payment”) and also paid a $
DYO shall not, directly or indirectly, offer, issue, sell, contract to sell (including without limitation short sale), grant any option for the sale of, pledge or otherwise dispose of or transfer any or all of the Stock Payment for a period of two years from the date of issuance.
Pursuant to the terms and conditions of the License Upon the occurrence of each of the following events (each a “Milestone”)), the Company shall make a cash payment (“Milestone Payment”) in the amount corresponding to such Milestone within thirty days after achievement of each Milestone:
| Milestone | AMOUNT | |||
| 1. Dosing of a first human patient in a Phase I or Phase I/II Clinical Trial for Licensed Product | $150,000 US | |||
| 2. Dosing of a first patient in a Phase III Clinical Trial for Licensed Product | $500,000 US | |||
| 3. FDA (US) Approval of a Licensed Product | $3,000,000 US | |||
| 4. EMA (EU) Approval of a Licensed Product | $1,500,000 US | |||
| 5. PMDA (JPN) Approval of a Licensed Product | $1,000,000 US | |||
| 6. Cumulative Net Sales of Licensed Products reach $100 Million | $2,000,000 US |
This License may be terminated by DYO in the event:
No licensed Method, Service or Product has been granted Patent Protection in at least one jurisdiction after the expiration of four years from execution
The sum of $2,000,000 shall not have been raised within 2 years of execution of the license
The Research Agreement shall not have been entered into as of thirty days subsequent to the Funding.
The Company shall not have achieved cumulative Net Sales of Licensed Product, Service and Methods of at least $10,000,000 as of a date that is ten years from the execution of the license
The Company shall fail to pay any consideration required under the license and such failure remains uncured for thirty days.
This License may be terminated by the Company in the event:
DYO shall be determined to not have exclusive unencumbered Patent Rights to the Technology in whole or in part.
Any other entity shall be determined to have the right- exercised or not- to utilize the Technology ( in whole or in part) to develop make, use, offer for sale, sell, perform, have performed export and import and sell products, methods and services which can reasonably be expected to be similar to or competitive with products, methods and services to be developed by the Company utilizing the rights granted by the License. .
DYO shall have failed to demonstrate during the course of due diligence to the satisfaction of the Company that the Technology can be effectively utilized for the purposes intended by this License
In the event that the Agreement is terminated pursuant to the any of the abovementioned the Stock Payment shall be promptly returned by DYO to the Company for cancellation.
Dr. Harry Lander serves as Chief Scientific Officer of the Company and is a shareholder of the Company. Dr. Harry Lander also serves as Managing Director of DYO and is a controlling shareholder of DYO.
On July 14, 2023 the Company’s Chief Executive
Officer made a $
On August 17, 2023 the Company’s Chief Executive Officer made
a $
On August 30, 2023 the Company’s Chief Executive Officer made
a $
On September 5, 2023 the Company’s Chief Executive Officer made
a $
On September 29, 2023 the Company’s Chief Executive Officer
made a $
NOTE 5. NOTES PAYABLE
| Bostonia Partners | $ | |||
| Zander Therapeutics Inc. | $ | |||
| Zander Biologics, Inc. | $ | |||
| Notes Payable, as of September 30, 2023 | $ | |||
$
$
$
$
$
$
$
| 11 |
NOTE 6. INVESTMENT SECURITIES
On March 11, 2021 the Company was paid common shares of Oncology Pharma, Inc. pursuant to an agreement entered into by and between the Company and Oncology Pharma, Inc. whereby the Company granted Oncology Pharma, Inc. an exclusive worldwide right and license for the development and commercialization of certain intellectual property controlled by the Company.
On September 30, 2023 the Company revalued common shares of Oncology Pharma, Inc. at the closing price of the common shares on the OTC Pink market.
As of September 30, 2023:
| Schedule Of Common Shares | ||||||||||||||
| 6,500 Common Shares of Oncology Pharma, Inc. | ||||||||||||||
| Basis | Fair Value | Total Unrealized Losses | Net Unrealized Gain or (Loss) during the quarter ended September 30, 2023 | |||||||||||
| $ | $ | $ | ( | ) | $ | ( | ) | |||||||
NOTE 7. STOCKHOLDERS’ EQUITY
The stockholders’ equity section of the Company contains the following class of capital stock as of September 30, 2023:
Common stock, $ par value; shares authorized: shares issued and outstanding.
With respect to each matter submitted to a vote of stockholders of the Corporation, each holder of Common Stock shall be entitled to cast that number of votes which is equivalent to the number of shares of Common Stock owned by such holder times one (1).
On any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of the Common Stock shall receive, out of assets legally available for distribution to the Company’s stockholders, a ratable share in the assets of the Corporation.
| 12 |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
CERTAIN FORWARD-LOOKING INFORMATION
Information provided in this Quarterly report on Form 10Q may contain forward-looking statements within the meaning of Section 21E or Securities Exchange Act of 1934 that are not historical facts and information. These statements represent the Company’s expectations or beliefs, including, but not limited to, statements concerning future and operating results, statements concerning industry performance, the Company’s operations, economic performance, financial conditions, margins and growth in sales of the Company’s products, capital expenditures, financing needs, as well assumptions related to the forgoing. For this purpose, any statements contained in this Quarterly Report that are not statement of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based on current expectations and involve various risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. The Company’s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by the Company with the Securities and Exchange Commission, including the Company’s Form 10-K for the period ended June 30, 2023 . All references to” We”, “Us”, “Company” or the “Company” refer to SYBLEU INC.
As of September 30, 2023 we had cash of $132 and as of June 30, 2023 we had cash of $3,786. .The decrease in cash of approximately 96% is attributable to cash expended in the operation of the Company’s business.
As of June 30, 2023 we had Prepaid Expenses of $24,762 and as of September 30, 2023 we had Prepaid Expenses of $18,468. The decrease in Prepaid Expenses of approximately 25% is attributable to:
The recognition of expenses during the reporting period connected to:
(a) 3,000,000 common shares issued to Joseph G Vaini, the Company’s Chief Executive Officer, pursuant to an employment agreement to be expensed over the life of the agreement
(b) 3,000,000 common shares issued to Dr. Harry Lander, the Company’s Chief Scientific Officer, pursuant to an employment agreement expensed over the life of the agreement.
(c) $15,000 prepaid pursuant to an agreement with Joanne Vaini ( the spouse of Joseph G. Vaini) to be expensed over the life of the agreement.
As of June 30, 2023 we had Investment Securities of $1,920 and as of September 30, 2023 we had Investment Securities of $423.
The decrease in Investment Securities of approximately 78% is attributable to the revaluation as of September 30, 2023 of 6,500 common shares of Oncology Pharma, Inc. at the closing price of the common shares on the OTC Pink market.
As of June 30, 2023 we had Expenses Accrued but Unpaid of $15,500 and as of September 30, 2023 we had Expenses Accrued but Unpaid of $6,914. The decrease of approximately 55% is primarily attributable to the reclassification of $12,500 of Expenses Accrued but Unpaid as Common Stock Payable.
As of June 30, 2023 we had Interest Accrued but Unpaid of $27,476 consisting completely of interest accrued but yet to be paid on Notes Payable and as of September 30, 2023 we had Interest Accrued but Unpaid of $35,573 consisting completely of interest accrued but yet to be paid on Notes Payable.
The increase in Interest Accrued but Unpaid of approximately 44% is attributable to interest accrued on Notes Payable during the quarter ended September 30, 2023 but yet to be paid.
During the quarter ended September 30, 2023 the Company recognized an Operating Loss of $126,724 and during the quarter ended September 30, 2022 the Company recognized an Operating Loss of $9,721. The increase of 1,200% is primarily attributable to the recognition of $105,000 of Intellectual Property acquisition costs recognized during the quarter ended September 30, 2023 connected to the purchase of certain intellectual property from Zander Biologics Inc. on June 30, 2023.
| 13 |
During the quarter ended September 30, 2023 the Company recognized a Net Loss of $145,639 and during the quarter ended September 30, 2022 the Company recognized an Operating Loss of $19,750. The increase of 637% is primarily attributable to the recognition of $105,000 of Intellectual Property acquisition costs recognized during the quarter ended September 30, 2023 connected to the purchase of certain intellectual property from Zander Biologics Inc. on June 30, 2023.
As of September 30, 2023 we had $132 in cash on hand and current liabilities of $240,422 such liabilities consisting of Income Tax Payable ,Accrued Expenses, Notes Payable and interest on Promissory Notes accrued but unpaid. We feel we will not be able to satisfy our cash requirements over the next twelve months and shall be required to seek additional financing.
Management plans to raise additional funds by obtaining governmental and nongovernmental grants as well as offering securities for cash. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings. Management can give no assurance that any governmental or nongovernmental grant will be obtained by the Company despite the Company’s best efforts.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As a smaller reporting company, as defined by Rule 229.10(f) (1) of Regulation S-K, we are not required to provide the information required by this Item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of Joseph G. Vaini who is the Company’s Principal Executive Officer , Chief Financial Officer and Principal Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. The Company’s disclosure controls and procedures are designed to provide a reasonable level of assurance of achieving the Company’s disclosure control objectives. The Company’s Principal Executive Officer and Principal Financial Officer has concluded that the Company’s disclosure controls and procedures are, in fact, effective at this reasonable assurance level as of the period covered.
Changes in Internal Controls over Financial Reporting
In connection with the evaluation of the Company’s internal controls during the period commencing on July 1, 2023 and ending on September 30, 2023, Joseph G. Vaini , who serves as the Company’s Principal Executive Officer and Principal Financial Officer, has determined that there were no changes to the Company’s internal controls over financial reporting that have been materially affected, or is reasonably likely to materially effect, the Company’s internal controls over financial reporting.
| 14 |
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.
There are no material pending legal proceedings to which the Company is a party or of which any of the Company’s property is the subject.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
There were no Unregistered Sales of Equity Securities during the quarter ended September 30, 2023.
EXHIBITS
| 15 |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SYBLEU INC | ||
| By: | /s/ Joseph G. Vaini | |
| Name: | Joseph G. Vaini | |
| Title: | Chairman, Chief Executive Officer | |
| Date: | October 16, 2023 |
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SYBLEU INC | ||
| By: | /s/ Joseph G. Vaini | |
| Name: | Joseph G. Vaini | |
| Title: | Chief Financial Officer, Director | |
| Date: | October 16, 2023 |
| 16 |
PROMISSORY NOTE (“NOTE”) - 10% SIMPLE INTEREST
| $5,500 | September 20, 2021 |
For VALUE RECEIVED, SYBLEU INC. (“Borrower”) promises to pay to Zander Therapeutics, Inc. (“Lender”) the principal sum of Five Thousand Five Hundred ($5,500) with accrued simple interest at the rate of 10% percent per annum on the balance. The said principal and accrued interest shall be payable in lawful money of the United States of America on August 2, 2024. This Note may be prepaid in whole or in part at any time without premium or penalty. The Borrower hereby waives any notice of the transfer of this Note by the Lender or by any subsequent holder of this Note, agrees to remain bound by the terms of this Note subsequent to any transfer, and agrees that the terms of this Note may be fully enforced by any subsequent holder of this Note. All terms and conditions of this Note shall be interpreted under the laws of the state of California and venue shall be the state of California.
SYBLEU INC.
By: /s/Joseph G Vaini
Its: Chairman and CEO
Accepted By:
Zander Therapeutics, Inc.
By:/s/David Koos
Its: Chairman
EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph G. Vaini, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Sybleu Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
| Date: October 16, 2023 | By: | /s/ Joseph G. Vaini |
| Joseph G. Vaini | ||
| Principal Executive Officer |
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph G. Vaini, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Sybleu Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
| Date: October 16, 2023 | By: | /s/ Joseph G. Vaini |
| Joseph G. Vaini | ||
| Principal Financial Officer |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly report of Sybleu Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: October 16, 2023 | By: | /s/ Joseph G. Vaini |
| Joseph
G. Vaini Chief Executive Officer |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Sybleu Inc. and will be retained by Sybleu Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly report of Sybleu Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: October 16, 2023 | By: | /s/ Joseph G. Vaini |
| Joseph
G. Vaini Principal Financial Officer |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Sybleu Inc. and will be retained by Sybleu Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Cover |
3 Months Ended |
|---|---|
|
Sep. 30, 2023
shares
| |
| Cover [Abstract] | |
| Document Type | 10-Q |
| Amendment Flag | false |
| Document Quarterly Report | true |
| Document Transition Report | false |
| Document Period End Date | Sep. 30, 2023 |
| Document Fiscal Period Focus | Q1 |
| Document Fiscal Year Focus | 2024 |
| Current Fiscal Year End Date | --06-30 |
| Entity File Number | 333-248059 |
| Entity Registrant Name | SYBLEU INC. |
| Entity Central Index Key | 0001818674 |
| Entity Tax Identification Number | 85-1412307 |
| Entity Incorporation, State or Country Code | WY |
| Entity Address, Address Line One | 1034 Throggs Neck Expressway |
| Entity Address, City or Town | Bronx |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10465 |
| City Area Code | (800) |
| Local Phone Number | 807-4631 |
| Entity Current Reporting Status | Yes |
| Entity Interactive Data Current | Yes |
| Entity Filer Category | Non-accelerated Filer |
| Entity Small Business | true |
| Entity Emerging Growth Company | false |
| Entity Shell Company | false |
| Entity Common Stock, Shares Outstanding | 10,613,492 |
Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares |
Sep. 30, 2023 |
Jun. 30, 2023 |
|---|---|---|
| Statement of Financial Position [Abstract] | ||
| Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
| Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
| Common Stock, Shares, Outstanding | 10,613,492 | 10,613,492 |
Condensed Statement of Cash Flows (Unaudited) - USD ($) |
3 Months Ended | |
|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
| Changes in Operating Assets and Liabilities | ||
| (Increase) Decrease in Prepaid Expenses | $ 6,294 | $ 3,188 |
| Increase (Decrease) in Accrued Expenses | 16,012 | |
| Increase( Decrease) in Unearned Income | (2,949) | (2,949) |
| Unrealized Loss (Gain) in Investment Securities | 1,498 | 6,539 |
| Increase in Common Stock Payable | 105,000 | |
| Increase in Amortization of Acquired Intangible Assets | 5,320 | |
| Increase in Capital Contributions | 5,311 | |
| Net Cash provided by (used) in Operating Activities | (9,154) | (12,972) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Increase (Decrease) in Notes Payable | 5,500 | |
| Net Cash provided by (used) in Financing Activities | 5,500 | 0 |
| Net Increase (Decrease) in Cash | (3,654) | (12,972) |
| Cash at Beginning of Period | 3,786 | 66,850 |
| Cash at End of Period | 132 | 53,878 |
| Supplemental Cash Flow Information: | ||
| Interest Paid | 0 | 0 |
| Income Taxes Paid | $ 0 | $ 0 |
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
3 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||
| ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SYBLEU INC. (“Company”) was organized June 12, 2020 under the laws of the State of Wyoming. The Company intends to engage primarily in the acquisition, licensing and development of regenerative medical applications up to the point of successful completion of Phase I and or Phase II clinical trials after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials. The primary factor to be considered by us in arriving at a decision to advance an application further to Phase III clinical trials would be a greater than anticipated indication of efficacy seen in Phase I trials. A. BASIS OF ACCOUNTING The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted a June 30 year-end. B. USE OF ESTIMATES The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. C. CASH EQUIVALENTS The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. D. FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value: Level 1: Quoted prices in active markets for identical assets or liabilities Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. E. RESEARCH AND DEVELOPMENT COSTS Research and development expenses relate primarily to the cost of discovery and research programs. Research and development costs are charged to expense as incurred. Research and development expenses consist mainly of evaluating potential Contract Research Organizations and filing of a provisional patent application. Stock issued for Employee Compensation Stock based compensation to employees is accounted for at the award’s fair value at grant, less the amount (if any) paid by the award recipient. During the quarter ended September 30, 2023 stock was issued for Employee Compensation. Stock issued for Non-Employee Services Stock Based compensation to non-employees is accounted for in accordance with ASC 505-50. ASC 505-50 requires entities to account for non-employee equity transactions based on either the fair value of the services received or the fair value of the equity instrument issued utilizing whichever measurement is most reliable During the quarter ended December 31, 2022 stock was issued for Non-Employee Services . Pursuant to ASC 505-50-30-11505-50-30-11 an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date:
G. INCOME TAXES The Company accounts for income taxes using the liability method prescribed by ASC 740, “Income Taxes.” Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of June 30, 2023 the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future. The Company generated a deferred tax credit through net operating loss carry forward. However, a valuation allowance of 100% has been established. Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19. The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. There were no Common Stock Equivalents as of June 30, 2023. I. INTANGIBLE ASSETS
The Company amortizes its intangible assets with definite useful lives over their estimated useful lives and reviews these assets for impairment. The Company’s acquired intangible assets with definite useful lives consists of a 50% interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to (a) the intellectual property disclosed in US Patent US11377442B2 (Small molecule agonists and antagonists of NR2F6 activity) and (b) ) the intellectual property disclosed in US Patent US US10472351B2 (Small molecule agonists and antagonists of NR2F6 activity in animals).
|
RECENT ACCOUNTING PRONOUNCEMENTS |
3 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Accounting Changes and Error Corrections [Abstract] | |
| RECENT ACCOUNTING PRONOUNCEMENTS | NOTE 2. RECENT ACCOUNTING PRONOUNCEMENTS The Company has adopted Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606). The guidance in this Update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. The Company has adopted the provisions of this ASU effective the fiscal year ended 2020. This guidance did not have a material impact on the Company’s Financial Statements. On February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842). The ASU requires organizations that lease assets, referred to as “lessees,” to recognize on the consolidated statement of financial position the rights and obligations created by those leases. The ASU also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. These disclosures include qualitative and quantitative requirements, providing additional information about the amounts recorded in the consolidated financial statements. The ASU on leases became effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This guidance is not expected to have a material impact on the Company’s financial statements. In June 2018, the FASB issued ASU No. 2018-07, Compensation - Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting. This ASU is intended to simplify aspects of share-based compensation issued to non-employees by making the guidance consistent with the accounting for employee share-based compensation. This ASU is effective for annual periods beginning after December 15, 2018 and interim periods within those annual periods, with early adoption permitted. This guidance is not expected to have a material impact on the Company’s financial statements. |
GOING CONCERN |
3 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| GOING CONCERN | NOTE 3. GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has generated net losses of $676,933 during the period from June 12, 2020 (inception) through September 30, 2023. This condition raises substantial doubt about the Company's ability to continue as a going concern. The Company's continuation as a going concern is dependent on its ability to meet its obligations, to obtain additional financing as may be required and ultimately to attain profitability. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management plans to raise additional funds by offering securities for cash. Management has yet to decide what type of offering the Company will use or how much capital the Company will raise. There is no guarantee that the Company will be able to raise any capital through any type of offerings. |
RELATED PARTY TRANSACTIONS. |
3 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | ||||||||||||||||||||||||||||||||||||
| RELATED PARTY TRANSACTIONS. | NOTE 4. RELATED PARTY TRANSACTIONS. The Company utilizes approximately 500 square feet of office space at 1034 Throggs Neck Expressway, Bronx NY 10465 provided to the Company by Joseph G. Vaini, the Company’s sole officer and director, on a month to month basis free of charge. The property is utilized as office space. We believe that the foregoing properties are adequate to meet our current needs for office space. On January 8, 2023 the Company entered into an agreement with Joanne Vaini whereby Joanne Vaini agreed to provide bookkeeping services for the Company for the period beginning January 9, 2023 and ending July 9, 2024 (“Agreement”) for total consideration consisting of $15,000. Joanne Vaini is the spouse of Joseph G. Vaini the Company’s sole officer and director. On June 26, 2023 the Company was granted an exclusive worldwide license by DYO Biotechnologies, Pty, Ltd (“DYO”) to (a) to make, have made, use, offer for sale, sell, perform, have performed export and import Licensed Products and Licensed Services; (b) to practice Licensed Methods; and (c) to use Technology, all in the Field, within the Territory and during the Term (the “License”). “Technology” is defined in the License
as” Artificial intelligence/machine learning engine designed to utilize existing chemical library structures in an integrated model
to predict highly specific and sensitive novel chemical structures for molecular targets.” “Licensed Services” are defined in the License as “any service performed by Company or Sublicensee for the benefit of a third party that, in whole or in part, (a) uses Technology; (b) uses Licensed Product(s); or (c) that practices or is enabled by a Licensed Method.” “Licensed Method” is defined in the License as “any method or process that uses Technology” “Field” is defined in the License as small molecule drug development and commercialization for human and/or animal health. “Territory” is defined in the License as “worldwide”. The Term of the License is the period of time beginning on the effective date of this Agreement which shall be June 26, 2023 and terminating on the last to expire Royalty Term. “Royalty Term” is defined in the License as that period of time beginning on the first commercial sale of a Licensed Product in a given country and, expires on a country-by-country basis with respect to each Licensed Product, upon the later of: (a) the expiration, abandonment, or invalidation of the last to expire, abandoned or invalidated Valid Claim of the Patent Rights in such country; (b) the expiration of any granted statutory period of marketing exclusivity within a country; and (c) 12 years from of the date of the first commercial sale of such Licensed Product in such country. Pursuant to the terms and conditions of the License the Company shall raise $2,000,000 US through either debt or equity financing within 2 years of execution of this Agreement (“Funding”). The Company shall enter into a research collaboration agreement with DYO upon mutually acceptable terms and conditions within 30 days of Funding (“Research Agreement). Substantially all of the Funding shall be utilized to enable the Technology for the benefit of developing Company’s existing and future small molecule drug intellectual property. It is anticipated that this research agreement will utilize substantially all of these funds over two years. It is agreed that the Company shall exclusively possess all right, title and interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to any and all inventions, discoveries, intellectual property and chemical structures resulting from this Research Agreement. Pursuant to the terms and conditions of the License the Company shall pay to DYO a Royalty equal to five percent (5%) of the Net Sales ( as such term is defined in the License) of any Licensed Method, Service or Product per annum. The License also imposes an obligation upon the Company to make minimum royalty payments to DYO over the course of the Term. Pursuant to the terms and conditions of the License the l Company paid to DYO common shares of the Company (“Stock Payment”) and also paid a $25,000 License Issuance Fee. DYO shall not, directly or indirectly, offer, issue, sell, contract to sell (including without limitation short sale), grant any option for the sale of, pledge or otherwise dispose of or transfer any or all of the Stock Payment for a period of two years from the date of issuance. Pursuant to the terms and conditions of the License Upon the occurrence of each of the following events (each a “Milestone”)), the Company shall make a cash payment (“Milestone Payment”) in the amount corresponding to such Milestone within thirty days after achievement of each Milestone:
This License may be terminated by DYO in the event: No licensed Method, Service or Product has been granted Patent Protection in at least one jurisdiction after the expiration of four years from execution The sum of $2,000,000 shall not have been raised within 2 years of execution of the license The Research Agreement shall not have been entered into as of thirty days subsequent to the Funding. The Company shall not have achieved cumulative Net Sales of Licensed Product, Service and Methods of at least $10,000,000 as of a date that is ten years from the execution of the license The Company shall fail to pay any consideration required under the license and such failure remains uncured for thirty days. This License may be terminated by the Company in the event: DYO shall be determined to not have exclusive unencumbered Patent Rights to the Technology in whole or in part. Any other entity shall be determined to have the right- exercised or not- to utilize the Technology ( in whole or in part) to develop make, use, offer for sale, sell, perform, have performed export and import and sell products, methods and services which can reasonably be expected to be similar to or competitive with products, methods and services to be developed by the Company utilizing the rights granted by the License. . DYO shall have failed to demonstrate during the course of due diligence to the satisfaction of the Company that the Technology can be effectively utilized for the purposes intended by this License In the event that the Agreement is terminated pursuant to the any of the abovementioned the Stock Payment shall be promptly returned by DYO to the Company for cancellation. Dr. Harry Lander serves as Chief Scientific Officer of the Company and is a shareholder of the Company. Dr. Harry Lander also serves as Managing Director of DYO and is a controlling shareholder of DYO. On July 14, 2023 the Company’s Chief Executive Officer made a $3,600 capital contribution to the Company. On August 17, 2023 the Company’s Chief Executive Officer made a $311 capital contribution to the Company. On August 30, 2023 the Company’s Chief Executive Officer made a $150 capital contribution to the Company. On September 5, 2023 the Company’s Chief Executive Officer made a $1,000 capital contribution to the Company. On September 29, 2023 the Company’s Chief Executive Officer made a $250 capital contribution to the Company. |
NOTES PAYABLE |
3 Months Ended | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | ||||||||||||||||||||||||||
| NOTES PAYABLE |
$10,000 owed by the Company to Bostonia Partners bears simple interest at 10% and is due and payable September 20, 2022. $30,000 owed by the Company to Bostonia Partners bears simple interest at 10% and is due and payable September 30, 2022. $100,000 owed by the Company to Bostonia Partners bears simple interest at 10% and is due and payable October 5, 2022. $12,500 owed by the Company to Zander Therapeutics, Inc bears simple interest at 10% and is due and payable April 4, 2024. $25,000 owed by the Company to Bostonia Partners bears simple interest at 10% and is due and payable June 29, 2024. $300,000 owed by the Company to Zander Biologics, Inc bears simple interest at 10% and is due and payable June 30, 2025. $5,500 owed by the Company to Zander Therapeutics, Inc bears simple interest at 10% and is due and payable August 2, 2024. |
|||||||||||||||||||||||||
INVESTMENT SECURITIES |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Investments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INVESTMENT SECURITIES | NOTE 6. INVESTMENT SECURITIES On March 11, 2021 the Company was paid common shares of Oncology Pharma, Inc. pursuant to an agreement entered into by and between the Company and Oncology Pharma, Inc. whereby the Company granted Oncology Pharma, Inc. an exclusive worldwide right and license for the development and commercialization of certain intellectual property controlled by the Company. On September 30, 2023 the Company revalued common shares of Oncology Pharma, Inc. at the closing price of the common shares on the OTC Pink market. As of September 30, 2023:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY |
3 Months Ended |
|---|---|
Sep. 30, 2023 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 7. STOCKHOLDERS’ EQUITY The stockholders’ equity section of the Company contains the following class of capital stock as of September 30, 2023: Common stock, $ par value; shares authorized: shares issued and outstanding. With respect to each matter submitted to a vote of stockholders of the Corporation, each holder of Common Stock shall be entitled to cast that number of votes which is equivalent to the number of shares of Common Stock owned by such holder times one (1). On any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of the Common Stock shall receive, out of assets legally available for distribution to the Company’s stockholders, a ratable share in the assets of the Corporation. |
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
3 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||
| BASIS OF ACCOUNTING | A. BASIS OF ACCOUNTING The financial statements have been prepared using the basis of accounting generally accepted in the United States of America. Under this basis of accounting, revenues are recorded as earned and expenses are recorded at the time liabilities are incurred. The Company has adopted a June 30 year-end. |
||||||
| USE OF ESTIMATES | B. USE OF ESTIMATES The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
||||||
| CASH EQUIVALENTS | C. CASH EQUIVALENTS The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. |
||||||
| FAIR VALUE OF FINANCIAL INSTRUMENTS | D. FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value is the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. A fair value hierarchy requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value: Level 1: Quoted prices in active markets for identical assets or liabilities Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. |
||||||
| RESEARCH AND DEVELOPMENT COSTS | E. RESEARCH AND DEVELOPMENT COSTS Research and development expenses relate primarily to the cost of discovery and research programs. Research and development costs are charged to expense as incurred. Research and development expenses consist mainly of evaluating potential Contract Research Organizations and filing of a provisional patent application. |
||||||
| STOCK BASED COMPENSATION |
Stock issued for Employee Compensation Stock based compensation to employees is accounted for at the award’s fair value at grant, less the amount (if any) paid by the award recipient. During the quarter ended September 30, 2023 stock was issued for Employee Compensation. Stock issued for Non-Employee Services Stock Based compensation to non-employees is accounted for in accordance with ASC 505-50. ASC 505-50 requires entities to account for non-employee equity transactions based on either the fair value of the services received or the fair value of the equity instrument issued utilizing whichever measurement is most reliable During the quarter ended December 31, 2022 stock was issued for Non-Employee Services . Pursuant to ASC 505-50-30-11505-50-30-11 an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date:
|
||||||
| INCOME TAXES | G. INCOME TAXES The Company accounts for income taxes using the liability method prescribed by ASC 740, “Income Taxes.” Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. As of June 30, 2023 the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future. The Company generated a deferred tax credit through net operating loss carry forward. However, a valuation allowance of 100% has been established. Interest and penalties on tax deficiencies recognized in accordance with ACS accounting standards are classified as income taxes in accordance with ASC Topic 740-10-50-19. |
||||||
| BASIC EARNINGS (LOSS) PER SHARE |
The Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) 260, "Earnings Per Share", which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock. ASC 260 requires the presentation of basic earnings (loss) per share and diluted earnings (loss) per share. The Company has adopted the provisions of ASC 260 effective from inception. Basic net loss per share amounts is computed by dividing the net income by the weighted average number of common shares outstanding. There were no Common Stock Equivalents as of June 30, 2023. |
||||||
| INTANGIBLE ASSETS | I. INTANGIBLE ASSETS
The Company amortizes its intangible assets with definite useful lives over their estimated useful lives and reviews these assets for impairment. The Company’s acquired intangible assets with definite useful lives consists of a 50% interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to (a) the intellectual property disclosed in US Patent US11377442B2 (Small molecule agonists and antagonists of NR2F6 activity) and (b) ) the intellectual property disclosed in US Patent US US10472351B2 (Small molecule agonists and antagonists of NR2F6 activity in animals).
|
NOTES PAYABLE (Tables) |
3 Months Ended | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | ||||||||||||||||||||||||||
| Schedule of related party debt |
|
|||||||||||||||||||||||||
INVESTMENT SECURITIES (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Investments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Common Shares |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) |
3 Months Ended |
|---|---|
|
Sep. 30, 2023
USD ($)
shares
| |
| Defined Benefit Plan Disclosure [Line Items] | |
| Uncertain tax positions | $ | $ 0 |
| Employee [Member] | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | 0 |
| Non Employee [Member] | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Number of shares issued for services | 0 |
GOING CONCERN (Details Narrative) |
40 Months Ended |
|---|---|
|
Sep. 30, 2023
USD ($)
| |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Net income loss | $ 676,933 |
RELATED PARTY TRANSACTIONS. (Details Narrative) - USD ($) |
3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Jan. 08, 2023 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Sep. 30, 2022 |
Sep. 06, 2023 |
Sep. 01, 2023 |
Aug. 18, 2023 |
Jul. 15, 2023 |
|
| Related Party Transaction [Line Items] | ||||||||
| [custom:StockIssuedDuringPeriodSharesIssuedForConsideration] | 309,000 | |||||||
| [custom:LicenseFees] | $ 2,949 | $ 25,000 | $ 2,949 | |||||
| [custom:CapitalContribution-0] | $ 250 | $ 1,000 | $ 150 | $ 311 | $ 3,600 | |||
| Joanne Vaini [Member] | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Related Party Transaction, Amounts of Transaction | $ 15,000 | |||||||
INVESTMENT SECURITIES (Details) - Oncology Pharma Inc [Member] |
3 Months Ended |
|---|---|
|
Sep. 30, 2023
USD ($)
| |
| Schedule of Investments [Line Items] | |
| Investment securities, basis | $ 177,450 |
| Investment securities, fair value | 423 |
| Investment securities, total unrealized losses | (177,027) |
| Investment securities, net unrealized gain or loss realized | $ (1,498) |
INVESTMENT SECURITIES (Details Narrative) - shares |
3 Months Ended | |
|---|---|---|
Mar. 11, 2021 |
Sep. 30, 2023 |
|
| Oncology Pharma Inc [Member] | ||
| Schedule of Investments [Line Items] | ||
| Number of shares issued for property dividend | 6,500 | 6,500 |
STOCKHOLDERS’ EQUITY (Details Narrative) - $ / shares |
Sep. 30, 2023 |
Jun. 30, 2023 |
|---|---|---|
| Equity [Abstract] | ||
| Common stock, par value | $ 0.0001 | $ 0.0001 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Common stock, shares issued | 10,613,492 | |
| Common stock, shares outstanding | 10,613,492 | 10,613,492 |
{
"version": "2.2",
"instance": {
"sybleu093023form10q.htm": {
"nsprefix": "CIK0001818674",
"nsuri": "http://sybleuinc.com/20230930",
"dts": {
"schema": {
"local": [
"cik0001818674-20230930.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
"https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
"https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
"https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
"https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
"https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
"https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
"https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
"https://xbrl.sec.gov/country/2022/country-2022.xsd",
"https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
]
},
"calculationLink": {
"local": [
"cik0001818674-20230930_cal.xml"
]
},
"definitionLink": {
"local": [
"cik0001818674-20230930_def.xml"
]
},
"labelLink": {
"local": [
"cik0001818674-20230930_lab.xml"
]
},
"presentationLink": {
"local": [
"cik0001818674-20230930_pre.xml"
]
},
"inline": {
"local": [
"sybleu093023form10q.htm"
]
}
},
"keyStandard": 105,
"keyCustom": 23,
"axisStandard": 3,
"axisCustom": 0,
"memberStandard": 3,
"memberCustom": 16,
"hidden": {
"total": 18,
"http://xbrl.sec.gov/dei/2022": 5,
"http://fasb.org/us-gaap/2022": 12,
"http://sybleuinc.com/20230930": 1
},
"contextCount": 87,
"entityCount": 1,
"segmentCount": 19,
"elementCount": 236,
"unitCount": 4,
"baseTaxonomies": {
"http://fasb.org/us-gaap/2022": 206,
"http://xbrl.sec.gov/dei/2022": 26
},
"report": {
"R1": {
"role": "http://sybleuinc.com/role/Cover",
"longName": "00000001 - Document - Cover",
"shortName": "Cover",
"isDefault": "true",
"groupType": "document",
"subGroupType": "",
"menuCat": "Cover",
"order": "1",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "dei:DocumentType",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"b",
"span",
"p",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "dei:DocumentType",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"b",
"span",
"p",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R2": {
"role": "http://sybleuinc.com/role/BalanceSheets",
"longName": "00000002 - Statement - Condensed Balance Sheets (Unaudited)",
"shortName": "Condensed Balance Sheets (Unaudited)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "2",
"firstAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:Cash",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:Cash",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R3": {
"role": "http://sybleuinc.com/role/BalanceSheetsParenthetical",
"longName": "00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical)",
"shortName": "Condensed Balance Sheets (Unaudited) (Parenthetical)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "parenthetical",
"menuCat": "Statements",
"order": "3",
"firstAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:CommonStockSharesAuthorized",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"us-gaap:CommonStockSharesAuthorized",
"span",
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true
},
"uniqueAnchor": null
},
"R4": {
"role": "http://sybleuinc.com/role/StatementOfOperations",
"longName": "00000004 - Statement - Condensed Statement of Operations (Unaudited)",
"shortName": "Condensed Statement of Operations (Unaudited)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "4",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "CIK0001818674:LicenseFees",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:Revenues",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"unique": true
}
},
"R5": {
"role": "http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit",
"longName": "00000005 - Statement - Condensed Statements of Shareholders Equity (Deficit) (Unaudited)",
"shortName": "Condensed Statements of Shareholders Equity (Deficit) (Unaudited)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "5",
"firstAnchor": {
"contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember",
"name": "us-gaap:StockholdersEquity",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember",
"name": "us-gaap:StockholdersEquity",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R6": {
"role": "http://sybleuinc.com/role/StatementOfCashFlows",
"longName": "00000006 - Statement - Condensed Statement of Cash Flows (Unaudited)",
"shortName": "Condensed Statement of Cash Flows (Unaudited)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "6",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:IncreaseDecreaseInPrepaidExpense",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:IncreaseDecreaseInPrepaidExpense",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R7": {
"role": "http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies",
"longName": "00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "7",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R8": {
"role": "http://sybleuinc.com/role/RecentAccountingPronouncements",
"longName": "00000008 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
"shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "8",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R9": {
"role": "http://sybleuinc.com/role/GoingConcern",
"longName": "00000009 - Disclosure - GOING CONCERN",
"shortName": "GOING CONCERN",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "9",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R10": {
"role": "http://sybleuinc.com/role/RelatedPartyTransactions.",
"longName": "00000010 - Disclosure - RELATED PARTY TRANSACTIONS.",
"shortName": "RELATED PARTY TRANSACTIONS.",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "10",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R11": {
"role": "http://sybleuinc.com/role/NotesPayable",
"longName": "00000011 - Disclosure - NOTES PAYABLE",
"shortName": "NOTES PAYABLE",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "11",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:DebtDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:DebtDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R12": {
"role": "http://sybleuinc.com/role/InvestmentSecurities",
"longName": "00000012 - Disclosure - INVESTMENT SECURITIES",
"shortName": "INVESTMENT SECURITIES",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "12",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:InvestmentHoldingsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:InvestmentHoldingsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R13": {
"role": "http://sybleuinc.com/role/StockholdersEquity",
"longName": "00000013 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
"shortName": "STOCKHOLDERS\u2019 EQUITY",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "13",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R14": {
"role": "http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies",
"longName": "00000014 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
"shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "policies",
"menuCat": "Policies",
"order": "14",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R15": {
"role": "http://sybleuinc.com/role/NotesPayableTables",
"longName": "00000015 - Disclosure - NOTES PAYABLE (Tables)",
"shortName": "NOTES PAYABLE (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "15",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:ScheduleOfDebtTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:DebtDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "us-gaap:ScheduleOfDebtTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:DebtDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R16": {
"role": "http://sybleuinc.com/role/InvestmentSecuritiesTables",
"longName": "00000016 - Disclosure - INVESTMENT SECURITIES (Tables)",
"shortName": "INVESTMENT SECURITIES (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "16",
"firstAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "CIK0001818674:ScheduleOfCommonSharesTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:InvestmentHoldingsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-07-01to2023-09-30",
"name": "CIK0001818674:ScheduleOfCommonSharesTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:InvestmentHoldingsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R17": {
"role": "http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
"longName": "00000017 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
"shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "17",
"firstAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:LiabilityForUncertainTaxPositionsCurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:IncomeTaxPolicyTextBlock",
"us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:LiabilityForUncertainTaxPositionsCurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:IncomeTaxPolicyTextBlock",
"us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R18": {
"role": "http://sybleuinc.com/role/GoingConcernDetailsNarrative",
"longName": "00000018 - Disclosure - GOING CONCERN (Details Narrative)",
"shortName": "GOING CONCERN (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "18",
"firstAnchor": {
"contextRef": "From2020-06-132023-09-30",
"name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2020-06-132023-09-30",
"name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R19": {
"role": "http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative",
"longName": "00000019 - Disclosure - RELATED PARTY TRANSACTIONS. (Details Narrative)",
"shortName": "RELATED PARTY TRANSACTIONS. (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "19",
"firstAnchor": {
"contextRef": "From2023-04-012023-06-30",
"name": "CIK0001818674:StockIssuedDuringPeriodSharesIssuedForConsideration",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-04-012023-06-30",
"name": "CIK0001818674:StockIssuedDuringPeriodSharesIssuedForConsideration",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R20": {
"role": "http://sybleuinc.com/role/NotesPayableDetails",
"longName": "00000020 - Disclosure - NOTES PAYABLE (Details)",
"shortName": "NOTES PAYABLE (Details)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "20",
"firstAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "CIK0001818674:NotesPayable1",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfDebtTableTextBlock",
"us-gaap:DebtDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "CIK0001818674:NotesPayable1",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfDebtTableTextBlock",
"us-gaap:DebtDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R21": {
"role": "http://sybleuinc.com/role/NotesPayableDetailsNarrative",
"longName": "00000021 - Disclosure - NOTES PAYABLE (Details Narrative)",
"shortName": "NOTES PAYABLE (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "21",
"firstAnchor": {
"contextRef": "AsOf2023-09-30_custom_BostoniaPartners1Member",
"name": "CIK0001818674:NotesPayableRelatedParty",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:DebtDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-09-30_custom_BostoniaPartners1Member",
"name": "CIK0001818674:NotesPayableRelatedParty",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:DebtDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R22": {
"role": "http://sybleuinc.com/role/InvestmentSecuritiesDetails",
"longName": "00000022 - Disclosure - INVESTMENT SECURITIES (Details)",
"shortName": "INVESTMENT SECURITIES (Details)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "22",
"firstAnchor": {
"contextRef": "AsOf2023-09-30_custom_OncologyPharmaIncMember",
"name": "CIK0001818674:InvestmentSecuritiesBasis",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"CIK0001818674:ScheduleOfCommonSharesTableTextBlock",
"us-gaap:InvestmentHoldingsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-09-30_custom_OncologyPharmaIncMember",
"name": "CIK0001818674:InvestmentSecuritiesBasis",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"CIK0001818674:ScheduleOfCommonSharesTableTextBlock",
"us-gaap:InvestmentHoldingsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R23": {
"role": "http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative",
"longName": "00000023 - Disclosure - INVESTMENT SECURITIES (Details Narrative)",
"shortName": "INVESTMENT SECURITIES (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "23",
"firstAnchor": {
"contextRef": "From2021-03-012021-03-11_custom_OncologyPharmaIncMember",
"name": "CIK0001818674:NumberOfSharesIssuedForPropertyDividend",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"p",
"us-gaap:InvestmentHoldingsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2021-03-012021-03-11_custom_OncologyPharmaIncMember",
"name": "CIK0001818674:NumberOfSharesIssuedForPropertyDividend",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"p",
"us-gaap:InvestmentHoldingsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true,
"unique": true
}
},
"R24": {
"role": "http://sybleuinc.com/role/StockholdersEquityDetailsNarrative",
"longName": "00000024 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
"shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "24",
"firstAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"unitRef": "USDPShares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-09-30",
"name": "us-gaap:CommonStockSharesIssued",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"span",
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "sybleu093023form10q.htm",
"unique": true
}
}
},
"tag": {
"dei_DocumentQuarterlyReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentQuarterlyReport",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Quarterly Report",
"documentation": "Boolean flag that is true only for a form used as an quarterly report."
}
}
},
"auth_ref": [
"r320"
]
},
"us-gaap_ProceedsFromIssuanceOfCommonStock": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ProceedsFromIssuanceOfCommonStock",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock issued for Cash",
"documentation": "The cash inflow from the additional capital contribution to the entity."
}
}
},
"auth_ref": [
"r25"
]
},
"dei_EntityAddressStateOrProvince": {
"xbrltype": "stateOrProvinceItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressStateOrProvince",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, State or Province",
"documentation": "Name of the state or province."
}
}
},
"auth_ref": []
},
"CIK0001818674_PatentApplicationCosts": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "PatentApplicationCosts",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_ResearchAndDevelopmentExpense",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Patent Application Costs"
}
}
},
"auth_ref": []
},
"dei_EntityAddressCountry": {
"xbrltype": "countryCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressCountry",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Country",
"documentation": "ISO 3166-1 alpha-2 country code."
}
}
},
"auth_ref": []
},
"us-gaap_ProfessionalAndContractServicesExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ProfessionalAndContractServicesExpense",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_ResearchAndDevelopmentExpense",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Staff Expenses",
"documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support."
}
}
},
"auth_ref": []
},
"us-gaap_LongTermNotesPayable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LongTermNotesPayable",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Note Payable",
"documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
}
}
},
"auth_ref": [
"r15"
]
},
"CIK0001818674_IncreaseDecreaseInSecuritiesAcceptedAsPayment": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "IncreaseDecreaseInSecuritiesAcceptedAsPayment",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 5.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "(Increase) Decrease in Securities accepted as\u00a0\u00a0Payment"
}
}
},
"auth_ref": []
},
"us-gaap_AdditionalPaidInCapitalCommonStock": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AdditionalPaidInCapitalCommonStock",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Contributed Capital",
"documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
}
}
},
"auth_ref": [
"r5"
]
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM FINANCING ACTIVITIES"
}
}
},
"auth_ref": []
},
"us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
"presentation": [
"http://sybleuinc.com/role/RecentAccountingPronouncements"
],
"lang": {
"en-us": {
"role": {
"label": "RECENT ACCOUNTING PRONOUNCEMENTS",
"documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle."
}
}
},
"auth_ref": [
"r88",
"r116",
"r117",
"r120",
"r121",
"r129",
"r130",
"r131",
"r162",
"r163",
"r166",
"r167",
"r225",
"r226",
"r227",
"r238",
"r241",
"r242",
"r243",
"r245",
"r246",
"r247",
"r254",
"r255",
"r256",
"r258",
"r270",
"r271",
"r272",
"r291",
"r292",
"r293",
"r294",
"r295"
]
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetCashProvidedByUsedInOperatingActivities",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net Cash provided by (used) in Operating Activities",
"label": "Net Cash Provided by (Used in) Operating Activities",
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
}
}
},
"auth_ref": [
"r26",
"r27",
"r30"
]
},
"us-gaap_RelatedPartyDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RelatedPartyDomain",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails",
"http://sybleuinc.com/role/NotesPayableDetailsNarrative",
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"auth_ref": [
"r204",
"r261",
"r262"
]
},
"CIK0001818674_NotesPayableRelatedParty": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "NotesPayableRelatedParty",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets",
"http://sybleuinc.com/role/NotesPayableDetails",
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Notes Payable, Related Party",
"verboseLabel": "Notes payable, related parties",
"terseLabel": "Notes payable related parties"
}
}
},
"auth_ref": []
},
"us-gaap_CommonStockMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CommonStockMember",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock [Member]",
"documentation": "Stock that is subordinate to all other stock of the issuer."
}
}
},
"auth_ref": [
"r332",
"r333",
"r339"
]
},
"dei_EntityAddressPostalZipCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressPostalZipCode",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Postal Zip Code",
"documentation": "Code for the postal or zip code"
}
}
},
"auth_ref": []
},
"us-gaap_IncreaseDecreaseInNotesPayableCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInNotesPayableCurrent",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase (Decrease)\u00a0\u00a0\u00a0in Notes Payable",
"documentation": "The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes."
}
}
},
"auth_ref": [
"r28"
]
},
"CIK0001818674_InterestAccruedButUnpaid": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "InterestAccruedButUnpaid",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 5.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Interest Accrued but Unpaid"
}
}
},
"auth_ref": []
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetCashProvidedByUsedInFinancingActivities",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net Cash provided by (used) in Financing Activities",
"label": "Net Cash Provided by (Used in) Financing Activities",
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
}
}
},
"auth_ref": [
"r106"
]
},
"us-gaap_ProfessionalFees": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ProfessionalFees",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_ResearchAndDevelopmentExpense",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Consulting Costs",
"documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
}
}
},
"auth_ref": [
"r81",
"r82"
]
},
"dei_CoverAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "CoverAbstract",
"lang": {
"en-us": {
"role": {
"label": "Cover [Abstract]",
"documentation": "Cover page."
}
}
},
"auth_ref": []
},
"CIK0001818674_CommonStockPayable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "CommonStockPayable",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock Payable"
}
}
},
"auth_ref": []
},
"CIK0001818674_UnearnedIncome": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "UnearnedIncome",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_Liabilities",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Unearned Income"
}
}
},
"auth_ref": []
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM OPERATING ACTIVITIES"
}
}
},
"auth_ref": []
},
"us-gaap_LiabilityForUncertainTaxPositionsCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LiabilityForUncertainTaxPositionsCurrent",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Uncertain tax positions",
"documentation": "Amount recognized for uncertainty in income taxes classified as current."
}
}
},
"auth_ref": [
"r12"
]
},
"CIK0001818674_IncreaseInCommonStockPayable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "IncreaseInCommonStockPayable",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase in Common Stock Payable"
}
}
},
"auth_ref": []
},
"us-gaap_AmortizationOfIntangibleAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AmortizationOfIntangibleAssets",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Amortization of Acquired Intangible Assets",
"documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
}
}
},
"auth_ref": [
"r29",
"r43",
"r46"
]
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Changes in Operating Assets and Liabilities"
}
}
},
"auth_ref": []
},
"us-gaap_ProfitLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ProfitLoss",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "NET INCOME ( LOSS)",
"label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
"documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
}
}
},
"auth_ref": [
"r89",
"r97",
"r98",
"r105",
"r111",
"r118",
"r127",
"r128",
"r150",
"r152",
"r156",
"r158",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r230",
"r233",
"r234",
"r240",
"r244",
"r285",
"r303",
"r305",
"r306",
"r330",
"r337"
]
},
"us-gaap_AdditionalPaidInCapital": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AdditionalPaidInCapital",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Additional Paid in capital",
"documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
}
}
},
"auth_ref": [
"r5",
"r307"
]
},
"CIK0001818674_LicenseFees": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "LicenseFees",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_Revenues",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative",
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "License Fees",
"verboseLabel": "[custom:LicenseFees]"
}
}
},
"auth_ref": []
},
"us-gaap_AcquiredFiniteLivedIntangibleAssetResidualValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AcquiredFiniteLivedIntangibleAssetResidualValue",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Acquired Intangible Assets, net of amortization",
"documentation": "The aggregate expected value at the end of their useful life of a major finite-lived intangible asset class acquired during the period either individually or as part of a group of assets (in either an asset acquisition or business combination). A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
}
}
},
"auth_ref": [
"r44"
]
},
"us-gaap_OtherAssetsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherAssetsAbstract",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "OTHER ASSETS"
}
}
},
"auth_ref": []
},
"us-gaap_EquityComponentDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "EquityComponentDomain",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
}
}
},
"auth_ref": [
"r48",
"r87",
"r100",
"r101",
"r102",
"r113",
"r114",
"r115",
"r119",
"r126",
"r128",
"r142",
"r165",
"r203",
"r211",
"r212",
"r213",
"r223",
"r224",
"r239",
"r248",
"r249",
"r250",
"r251",
"r252",
"r253",
"r257",
"r288",
"r289",
"r290"
]
},
"dei_CountryRegion": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "CountryRegion",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Country Region",
"documentation": "Region code of country"
}
}
},
"auth_ref": []
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails",
"http://sybleuinc.com/role/NotesPayableDetailsNarrative",
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative",
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Related Party [Axis]",
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"auth_ref": [
"r204",
"r261",
"r273",
"r274",
"r275",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r282",
"r283",
"r284",
"r342"
]
},
"CIK0001818674_DecreaseInAdditionalPaidInCapital": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "DecreaseInAdditionalPaidInCapital",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 9.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Decrease in Additional Paid in Capital",
"label": "DecreaseInAdditionalPaidInCapital"
}
}
},
"auth_ref": []
},
"dei_CityAreaCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "CityAreaCode",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "City Area Code",
"documentation": "Area code of city"
}
}
},
"auth_ref": []
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Cash at Beginning of Period",
"periodEndLabel": "Cash at End of Period",
"label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
}
}
},
"auth_ref": [
"r26",
"r31",
"r34"
]
},
"us-gaap_AccruedLiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AccruedLiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Expenses Accrued but Unpaid",
"documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
}
}
},
"auth_ref": [
"r12"
]
},
"CIK0001818674_IntellectualPropertyAcquisitionCosts": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "IntellectualPropertyAcquisitionCosts",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Intellectual Property Acquisition Costs"
}
}
},
"auth_ref": []
},
"dei_Extension": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "Extension",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Extension",
"documentation": "Extension number for local phone number."
}
}
},
"auth_ref": []
},
"CIK0001818674_TransferAgencyFees": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "TransferAgencyFees",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_GeneralAndAdministrativeExpense",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Transfer Agency Fees"
}
}
},
"auth_ref": []
},
"dei_LocalPhoneNumber": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "LocalPhoneNumber",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Local Phone Number",
"documentation": "Local phone number for entity."
}
}
},
"auth_ref": []
},
"us-gaap_Investments": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "Investments",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_OtherAssets",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Investment Securities",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
}
}
},
"auth_ref": [
"r77"
]
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StatementOfFinancialPositionAbstract",
"lang": {
"en-us": {
"role": {
"label": "Statement of Financial Position [Abstract]"
}
}
},
"auth_ref": []
},
"CIK0001818674_ConsultingRelatedParty": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ConsultingRelatedParty",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Consulting, Related Party"
}
}
},
"auth_ref": []
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net Increase (Decrease) in Cash",
"label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
"documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
}
}
},
"auth_ref": [
"r26",
"r60"
]
},
"us-gaap_AdditionalPaidInCapitalMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AdditionalPaidInCapitalMember",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Additional Paid-in Capital [Member]",
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
}
}
},
"auth_ref": [
"r211",
"r212",
"r213",
"r332",
"r333",
"r334",
"r339"
]
},
"us-gaap_StatementEquityComponentsAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StatementEquityComponentsAxis",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Components [Axis]",
"documentation": "Information by component of equity."
}
}
},
"auth_ref": [
"r16",
"r48",
"r87",
"r100",
"r101",
"r102",
"r113",
"r114",
"r115",
"r119",
"r126",
"r128",
"r142",
"r165",
"r203",
"r211",
"r212",
"r213",
"r223",
"r224",
"r239",
"r248",
"r249",
"r250",
"r251",
"r252",
"r253",
"r257",
"r288",
"r289",
"r290"
]
},
"CIK0001818674_ConsultingAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ConsultingAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Consulting:"
}
}
},
"auth_ref": []
},
"us-gaap_NetIncomeLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetIncomeLoss",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Net Loss",
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
}
}
},
"auth_ref": [
"r18",
"r30",
"r70",
"r78",
"r89",
"r97",
"r98",
"r102",
"r111",
"r118",
"r122",
"r123",
"r124",
"r125",
"r127",
"r128",
"r139",
"r150",
"r152",
"r156",
"r158",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r240",
"r244",
"r303",
"r337"
]
},
"CIK0001818674_AccountingExpenses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "AccountingExpenses",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "CIK0001818674_ConsultingNet",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Accounting"
}
}
},
"auth_ref": []
},
"us-gaap_StatementLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StatementLineItems",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Statement [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"CIK0001818674_SecuritiesDepositoryConsulting": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "SecuritiesDepositoryConsulting",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "CIK0001818674_ConsultingNet",
"weight": 1.0,
"order": 5.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Securities Depository Consulting"
}
}
},
"auth_ref": []
},
"CIK0001818674_StockCancellationExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "StockCancellationExpense",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Stock Cancellation Expense"
}
}
},
"auth_ref": []
},
"us-gaap_StatementOfCashFlowsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StatementOfCashFlowsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"auth_ref": []
},
"us-gaap_Cash": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "Cash",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Cash",
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
}
}
},
"auth_ref": [
"r296",
"r297",
"r307",
"r328"
]
},
"us-gaap_IncreaseDecreaseInPrepaidExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInPrepaidExpense",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "(Increase) Decrease in Prepaid Expenses",
"label": "Increase (Decrease) in Prepaid Expense",
"documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
}
}
},
"auth_ref": [
"r28"
]
},
"CIK0001818674_ConsultingNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ConsultingNet",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Consulting",
"label": "ConsultingNet"
}
}
},
"auth_ref": []
},
"dei_Security12bTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "Security12bTitle",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Title of 12(b) Security",
"documentation": "Title of a 12(b) registered security."
}
}
},
"auth_ref": [
"r309"
]
},
"CIK0001818674_DecreaseInCommonStock": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "DecreaseInCommonStock",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 8.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Decrease in Common Stock",
"label": "DecreaseInCommonStock"
}
}
},
"auth_ref": []
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/GoingConcernDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Net income loss",
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
}
}
},
"auth_ref": [
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141"
]
},
"CIK0001818674_BasicAndFullyDilutedLossPerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "BasicAndFullyDilutedLossPerShare",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "BASIC AND FULLY DILUTED LOSS PER SHARE"
}
}
},
"auth_ref": []
},
"CIK0001818674_WeightedAverageNumberOfCommonSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "WeightedAverageNumberOfCommonSharesOutstanding",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING"
}
}
},
"auth_ref": []
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StatementOfStockholdersEquityAbstract",
"auth_ref": []
},
"CIK0001818674_CapitalContributions": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "CapitalContributions",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows",
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Capital Contributions during the three months ended September 30, 2023",
"verboseLabel": "Increase in Capital Contributions"
}
}
},
"auth_ref": []
},
"us-gaap_StatementTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StatementTable",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Statement [Table]",
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
}
}
},
"auth_ref": [
"r113",
"r114",
"r115",
"r142",
"r268"
]
},
"dei_NoTradingSymbolFlag": {
"xbrltype": "trueItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "NoTradingSymbolFlag",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "No Trading Symbol Flag",
"documentation": "Boolean flag that is true only for a security having no trading symbol."
}
}
},
"auth_ref": []
},
"dei_DocumentTransitionReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentTransitionReport",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Transition Report",
"documentation": "Boolean flag that is true only for a form used as a transition report."
}
}
},
"auth_ref": [
"r323"
]
},
"CIK0001818674_CommonStockIssuedForPaymentOfExpenses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "CommonStockIssuedForPaymentOfExpenses",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Common Stock Issued for payment of expenses",
"label": "CommonStockIssuedForPaymentOfExpenses"
}
}
},
"auth_ref": []
},
"CIK0001818674_AdditionsSubtractionsCommonStockPayable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "AdditionsSubtractionsCommonStockPayable",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Additions (Subtractions) Common Stock Payable\u00a0\u00a0three months ended September 30, 2023"
}
}
},
"auth_ref": []
},
"us-gaap_AssetsCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AssetsCurrent",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_Assets",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Current Assets",
"label": "Assets, Current",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
}
}
},
"auth_ref": [
"r90",
"r95",
"r111",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r231",
"r235",
"r244",
"r307",
"r337",
"r338",
"r343"
]
},
"us-gaap_CostsAndExpenses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CostsAndExpenses",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Costs and Expenses",
"label": "Costs and Expenses",
"documentation": "Total costs of sales and operating expenses for the period."
}
}
},
"auth_ref": [
"r19"
]
},
"dei_SolicitingMaterial": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "SolicitingMaterial",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Soliciting Material",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
}
}
},
"auth_ref": [
"r318"
]
},
"dei_EntityFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityFileNumber",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity File Number",
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
}
}
},
"auth_ref": []
},
"us-gaap_DefinedBenefitPlanDisclosureLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DefinedBenefitPlanDisclosureLineItems",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails",
"http://sybleuinc.com/role/NotesPayableDetailsNarrative",
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Defined Benefit Plan Disclosure [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"us-gaap_TaxesAndLicenses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "TaxesAndLicenses",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Licensing Expenses",
"documentation": "Amount of tax expense, excluding income, excise, production and property taxes, and licenses and fees not related to production."
}
}
},
"auth_ref": []
},
"us-gaap_AssetsCurrentAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AssetsCurrentAbstract",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "CURRENT ASSETS"
}
}
},
"auth_ref": []
},
"us-gaap_ScheduleOfDebtTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ScheduleOfDebtTableTextBlock",
"presentation": [
"http://sybleuinc.com/role/NotesPayableTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of related party debt",
"documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
}
}
},
"auth_ref": []
},
"dei_EntityPrimarySicNumber": {
"xbrltype": "sicNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityPrimarySicNumber",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Primary SIC Number",
"documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
}
}
},
"auth_ref": [
"r322"
]
},
"us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_ProfitLoss",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "NET INCOME ( LOSS) before taxes",
"label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
"documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
}
}
},
"auth_ref": [
"r17",
"r64",
"r69",
"r79",
"r150",
"r152",
"r156",
"r158",
"r285",
"r303"
]
},
"us-gaap_IncomeTaxExpenseBenefit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncomeTaxExpenseBenefit",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_ProfitLoss",
"weight": -1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Provision for Income Taxes",
"label": "Income Tax Expense (Benefit)",
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
}
}
},
"auth_ref": [
"r112",
"r127",
"r128",
"r149",
"r218",
"r228",
"r229",
"r287"
]
},
"us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AccountingChangesAndErrorCorrectionsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Accounting Changes and Error Corrections [Abstract]"
}
}
},
"auth_ref": []
},
"dei_EntityTaxIdentificationNumber": {
"xbrltype": "employerIdItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityTaxIdentificationNumber",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Tax Identification Number",
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
}
}
},
"auth_ref": [
"r310"
]
},
"us-gaap_EquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "EquityAbstract",
"lang": {
"en-us": {
"role": {
"label": "Equity [Abstract]"
}
}
},
"auth_ref": []
},
"us-gaap_TaxesPayableCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "TaxesPayableCurrent",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Income Taxes Payable",
"documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
}
}
},
"auth_ref": [
"r10"
]
},
"us-gaap_UseOfEstimates": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "UseOfEstimates",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "USE OF ESTIMATES",
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
}
}
},
"auth_ref": [
"r38",
"r39",
"r40",
"r143",
"r144",
"r145",
"r146"
]
},
"us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CashAndCashEquivalentsPolicyTextBlock",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "CASH EQUIVALENTS",
"documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
}
}
},
"auth_ref": [
"r32"
]
},
"us-gaap_OperatingIncomeLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OperatingIncomeLoss",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "OPERATING Income( LOSS)",
"label": "Operating Income (Loss)",
"documentation": "The net result for the period of deducting operating expenses from operating revenues."
}
}
},
"auth_ref": [
"r150",
"r152",
"r156",
"r158",
"r303"
]
},
"us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Unrealized Gain (Loss) on Investment Securities",
"documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
}
}
},
"auth_ref": []
},
"dei_EntityIncorporationStateCountryCode": {
"xbrltype": "edgarStateCountryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityIncorporationStateCountryCode",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Incorporation, State or Country Code",
"documentation": "Two-character EDGAR code representing the state or country of incorporation."
}
}
},
"auth_ref": []
},
"us-gaap_IncomeTaxesPaidNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncomeTaxesPaidNet",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Income Taxes Paid",
"documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
}
}
},
"auth_ref": [
"r33"
]
},
"dei_CurrentFiscalYearEndDate": {
"xbrltype": "gMonthDayItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "CurrentFiscalYearEndDate",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Current Fiscal Year End Date",
"documentation": "End date of current fiscal year in the format --MM-DD."
}
}
},
"auth_ref": []
},
"dei_WrittenCommunications": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "WrittenCommunications",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Written Communications",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
}
}
},
"auth_ref": [
"r326"
]
},
"us-gaap_OtherNonoperatingIncomeExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherNonoperatingIncomeExpense",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "TOTAL OTHER INCOME (EXPENSES)",
"label": "Other Nonoperating Income (Expense)",
"documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
}
}
},
"auth_ref": [
"r24"
]
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RetainedEarningsAccumulatedDeficit",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Retained Earnings (Deficit)",
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
}
}
},
"auth_ref": [
"r6",
"r49",
"r75",
"r291",
"r295",
"r307"
]
},
"dei_PreCommencementIssuerTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "PreCommencementIssuerTenderOffer",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-commencement Issuer Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
}
}
},
"auth_ref": [
"r315"
]
},
"us-gaap_NotesPayable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NotesPayable",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Notes Payable",
"documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
}
}
},
"auth_ref": [
"r2",
"r67",
"r74"
]
},
"us-gaap_AssetsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AssetsAbstract",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "ASSETS"
}
}
},
"auth_ref": []
},
"us-gaap_CostsAndExpensesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CostsAndExpensesAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "COSTS AND EXPENSES"
}
}
},
"auth_ref": []
},
"dei_EntityWellKnownSeasonedIssuer": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityWellKnownSeasonedIssuer",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Well-known Seasoned Issuer",
"documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
}
}
},
"auth_ref": [
"r325"
]
},
"dei_PreCommencementTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "PreCommencementTenderOffer",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-commencement Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
}
}
},
"auth_ref": [
"r316"
]
},
"dei_EntityVoluntaryFilers": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityVoluntaryFilers",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Voluntary Filers",
"documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
}
}
},
"auth_ref": []
},
"dei_AmendmentFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "AmendmentFlag",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Amendment Flag",
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
}
}
},
"auth_ref": []
},
"us-gaap_RetainedEarningsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RetainedEarningsMember",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Retained Earnings [Member]",
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
}
}
},
"auth_ref": [
"r87",
"r113",
"r114",
"r115",
"r119",
"r126",
"r128",
"r165",
"r211",
"r212",
"r213",
"r223",
"r224",
"r239",
"r288",
"r290"
]
},
"us-gaap_IncomeTaxPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncomeTaxPolicyTextBlock",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "INCOME TAXES",
"documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
}
}
},
"auth_ref": [
"r99",
"r216",
"r217",
"r219",
"r220",
"r221",
"r222"
]
},
"us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "STOCK BASED COMPENSATION",
"documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
}
}
},
"auth_ref": [
"r205",
"r206",
"r207",
"r208",
"r209",
"r210",
"r214",
"r215"
]
},
"dei_EntityCurrentReportingStatus": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityCurrentReportingStatus",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Current Reporting Status",
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
}
}
},
"auth_ref": []
},
"dei_EntityShellCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityShellCompany",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Shell Company",
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
}
}
},
"auth_ref": [
"r310"
]
},
"us-gaap_OtherNoncashExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherNoncashExpense",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Rent",
"documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other."
}
}
},
"auth_ref": [
"r30"
]
},
"us-gaap_ScheduleOfInvestmentsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ScheduleOfInvestmentsLineItems",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails",
"http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Investments [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"dei_EntityFilerCategory": {
"xbrltype": "filerCategoryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityFilerCategory",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Filer Category",
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
}
}
},
"auth_ref": [
"r310"
]
},
"dei_EntityBankruptcyProceedingsReportingCurrent": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityBankruptcyProceedingsReportingCurrent",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Bankruptcy Proceedings, Reporting Current",
"documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
}
}
},
"auth_ref": [
"r314"
]
},
"us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
"documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
}
}
},
"auth_ref": [
"r3",
"r4",
"r48",
"r49"
]
},
"dei_DocumentType": {
"xbrltype": "submissionTypeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentType",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Type",
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
}
}
},
"auth_ref": []
},
"us-gaap_InvestmentHoldingsTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "InvestmentHoldingsTextBlock",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecurities"
],
"lang": {
"en-us": {
"role": {
"label": "INVESTMENT SECURITIES",
"documentation": "The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts)."
}
}
},
"auth_ref": [
"r83",
"r84",
"r85",
"r298",
"r299"
]
},
"us-gaap_LiabilitiesCurrentAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LiabilitiesCurrentAbstract",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Current Liabilities:"
}
}
},
"auth_ref": []
},
"dei_DocumentAnnualReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentAnnualReport",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Annual Report",
"documentation": "Boolean flag that is true only for a form used as an annual report."
}
}
},
"auth_ref": [
"r319",
"r321",
"r322"
]
},
"CIK0001818674_CapitalContribution": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "CapitalContribution",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "[custom:CapitalContribution-0]"
}
}
},
"auth_ref": []
},
"us-gaap_InformationTechnologyAndDataProcessing": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "InformationTechnologyAndDataProcessing",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "CIK0001818674_ConsultingNet",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Information Technology Consulting",
"documentation": "The amount of expenses incurred in the period for information technology and data processing products and services."
}
}
},
"auth_ref": [
"r23"
]
},
"us-gaap_Revenues": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "Revenues",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "TOTAL REVENUES",
"label": "Revenues",
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
}
}
},
"auth_ref": [
"r103",
"r111",
"r147",
"r148",
"r151",
"r154",
"r155",
"r159",
"r160",
"r161",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r244",
"r285",
"r337"
]
},
"dei_DocumentPeriodEndDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentPeriodEndDate",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Period End Date",
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
}
}
},
"auth_ref": []
},
"CIK0001818674_IncreaseInAmortizationOfAcquiredIntangibleAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "IncreaseInAmortizationOfAcquiredIntangibleAssets",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase in Amortization of Acquired Intangible Assets"
}
}
},
"auth_ref": []
},
"CIK0001818674_ScheduleOfCommonSharesTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ScheduleOfCommonSharesTableTextBlock",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule Of Common Shares"
}
}
},
"auth_ref": []
},
"us-gaap_RevenuesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RevenuesAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "REVENUES"
}
}
},
"auth_ref": []
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LiabilitiesAndStockholdersEquity",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)",
"label": "Liabilities and Equity",
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
}
}
},
"auth_ref": [
"r9",
"r68",
"r76",
"r307",
"r331",
"r336",
"r341"
]
},
"CIK0001818674_StockIssuedDuringPeriodSharesIssuedForConsideration": {
"xbrltype": "sharesItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "StockIssuedDuringPeriodSharesIssuedForConsideration",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "[custom:StockIssuedDuringPeriodSharesIssuedForConsideration]"
}
}
},
"auth_ref": []
},
"us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "SubstantialDoubtAboutGoingConcernTextBlock",
"presentation": [
"http://sybleuinc.com/role/GoingConcern"
],
"lang": {
"en-us": {
"role": {
"label": "GOING CONCERN",
"documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
}
}
},
"auth_ref": [
"r0"
]
},
"CIK0001818674_InvestmentSecuritiesBasis": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "InvestmentSecuritiesBasis",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Investment securities, basis"
}
}
},
"auth_ref": []
},
"us-gaap_DebtInstrumentMaturityDate": {
"xbrltype": "dateItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DebtInstrumentMaturityDate",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Maturity date",
"documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
}
}
},
"auth_ref": [
"r96",
"r304",
"r340"
]
},
"us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Related Party Transactions, by Related Party [Table]",
"documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
}
}
},
"auth_ref": [
"r62",
"r63"
]
},
"us-gaap_Liabilities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "Liabilities",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Liabilities",
"label": "Liabilities",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
}
}
},
"auth_ref": [
"r11",
"r111",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r232",
"r235",
"r236",
"r244",
"r302",
"r337",
"r343",
"r344"
]
},
"CIK0001818674_NotesPayable1": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "NotesPayable1",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Notes payable, related parties"
}
}
},
"auth_ref": []
},
"dei_DocumentsIncorporatedByReferenceTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentsIncorporatedByReferenceTextBlock",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Documents Incorporated by Reference [Text Block]",
"documentation": "Documents incorporated by reference."
}
}
},
"auth_ref": [
"r311"
]
},
"dei_EntityCommonStockSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityCommonStockSharesOutstanding",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Common Stock, Shares Outstanding",
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
}
}
},
"auth_ref": []
},
"us-gaap_DebtInstrumentInterestRateDuringPeriod": {
"xbrltype": "percentItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DebtInstrumentInterestRateDuringPeriod",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Interest rate",
"documentation": "The average effective interest rate during the reporting period."
}
}
},
"auth_ref": [
"r14",
"r61",
"r187"
]
},
"CIK0001818674_InvestmentSecuritiesTotalUnrealizedLosses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "InvestmentSecuritiesTotalUnrealizedLosses",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Investment securities, total unrealized losses"
}
}
},
"auth_ref": []
},
"us-gaap_IncomeStatementAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncomeStatementAbstract",
"lang": {
"en-us": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"auth_ref": []
},
"CIK0001818674_NumberOfSharesIssuedForPropertyDividend": {
"xbrltype": "sharesItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "NumberOfSharesIssuedForPropertyDividend",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Number of shares issued for property dividend"
}
}
},
"auth_ref": []
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RelatedPartyTransactionsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Related Party Transactions [Abstract]"
}
}
},
"auth_ref": []
},
"us-gaap_RelatedPartyTransactionLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RelatedPartyTransactionLineItems",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transaction [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": []
},
"us-gaap_LegalFees": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LegalFees",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "CIK0001818674_ConsultingNet",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Legal Fees",
"documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
}
}
},
"auth_ref": [
"r20"
]
},
"us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RelatedPartyTransactionAmountsOfTransaction",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transaction, Amounts of Transaction",
"documentation": "Amount of transactions with related party during the financial reporting period."
}
}
},
"auth_ref": [
"r63",
"r261"
]
},
"dei_EntityEmergingGrowthCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityEmergingGrowthCompany",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Emerging Growth Company",
"documentation": "Indicate if registrant meets the emerging growth company criteria."
}
}
},
"auth_ref": [
"r310"
]
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustments to reconcile net Income (loss) to net cash"
}
}
},
"auth_ref": []
},
"us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherNonoperatingIncomeExpenseAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "OTHER INCOME AND EXPENSES"
}
}
},
"auth_ref": []
},
"us-gaap_LiabilitiesNoncurrentAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LiabilitiesNoncurrentAbstract",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Long Term Liabilities:"
}
}
},
"auth_ref": []
},
"dei_EntityExTransitionPeriod": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityExTransitionPeriod",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Elected Not To Use the Extended Transition Period",
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
}
}
},
"auth_ref": [
"r327"
]
},
"us-gaap_OtherGeneralAndAdministrativeExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherGeneralAndAdministrativeExpense",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_GeneralAndAdministrativeExpense",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Other General and Administrative Expenses",
"documentation": "Amount of general and administrative expense classified as other."
}
}
},
"auth_ref": [
"r21"
]
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "SupplementalCashFlowInformationAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Supplemental Cash Flow Information:"
}
}
},
"auth_ref": []
},
"us-gaap_IncreaseDecreaseInUnearnedPremiums": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInUnearnedPremiums",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 6.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase( Decrease) in Unearned Income",
"documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income."
}
}
},
"auth_ref": [
"r28"
]
},
"dei_EntityRegistrantName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityRegistrantName",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Registrant Name",
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
}
}
},
"auth_ref": [
"r310"
]
},
"dei_EntityPublicFloat": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityPublicFloat",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Public Float",
"documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
}
}
},
"auth_ref": []
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
}
}
},
"auth_ref": []
},
"us-gaap_StockholdersEquity": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StockholdersEquity",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets",
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Stockholders' Equity (Deficit)",
"periodStartLabel": "Beginning balance, value",
"periodEndLabel": "Ending balance, value",
"label": "Stockholders' Equity Attributable to Parent",
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity."
}
}
},
"auth_ref": [
"r4",
"r7",
"r8",
"r42",
"r307",
"r331",
"r336",
"r341"
]
},
"dei_SecurityExchangeName": {
"xbrltype": "edgarExchangeCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "SecurityExchangeName",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Security Exchange Name",
"documentation": "Name of the Exchange on which a security is registered."
}
}
},
"auth_ref": [
"r312"
]
},
"dei_LegalEntityAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "LegalEntityAxis",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails",
"http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Legal Entity [Axis]",
"documentation": "The set of legal entities associated with a report."
}
}
},
"auth_ref": []
},
"us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StockIssuedDuringPeriodSharesIssuedForServices",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Number of shares issued for services",
"documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
}
}
},
"auth_ref": []
},
"dei_Security12gTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "Security12gTitle",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Title of 12(g) Security",
"documentation": "Title of a 12(g) registered security."
}
}
},
"auth_ref": [
"r313"
]
},
"us-gaap_InterestPaidNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "InterestPaidNet",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Interest Paid",
"documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
}
}
},
"auth_ref": [
"r104",
"r107",
"r108"
]
},
"dei_EntityDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityDomain",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails",
"http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
}
}
},
"auth_ref": []
},
"dei_TradingSymbol": {
"xbrltype": "tradingSymbolItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "TradingSymbol",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Symbol",
"documentation": "Trading symbol of an instrument as listed on an exchange."
}
}
},
"auth_ref": []
},
"us-gaap_OtherExpenses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherExpenses",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "CIK0001818674_ConsultingNet",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Other Consulting",
"documentation": "Amount of expense classified as other."
}
}
},
"auth_ref": [
"r22",
"r80"
]
},
"dei_SecurityReportingObligation": {
"xbrltype": "securityReportingObligationItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "SecurityReportingObligation",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Security Reporting Obligation",
"documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
}
}
},
"auth_ref": [
"r317"
]
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"presentation": [
"http://sybleuinc.com/role/StockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "STOCKHOLDERS\u2019 EQUITY",
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income."
}
}
},
"auth_ref": [
"r50",
"r110",
"r191",
"r192",
"r193",
"r194",
"r195",
"r196",
"r197",
"r198",
"r199",
"r200",
"r201",
"r202",
"r203",
"r237"
]
},
"us-gaap_DebtDisclosureAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DebtDisclosureAbstract",
"lang": {
"en-us": {
"role": {
"label": "Debt Disclosure [Abstract]"
}
}
},
"auth_ref": []
},
"dei_EntityCentralIndexKey": {
"xbrltype": "centralIndexKeyItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityCentralIndexKey",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Central Index Key",
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
}
}
},
"auth_ref": [
"r310"
]
},
"us-gaap_LiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "LiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_Liabilities",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Current Liabilities",
"label": "Liabilities, Current",
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
}
}
},
"auth_ref": [
"r13",
"r91",
"r111",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r232",
"r235",
"r236",
"r244",
"r307",
"r337",
"r343",
"r344"
]
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions."
],
"lang": {
"en-us": {
"role": {
"label": "RELATED PARTY TRANSACTIONS.",
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
}
}
},
"auth_ref": [
"r259",
"r260",
"r262",
"r263",
"r264"
]
},
"dei_EntitySmallBusiness": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntitySmallBusiness",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Small Business",
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
}
}
},
"auth_ref": [
"r310"
]
},
"CIK0001818674_ContributedCapitalMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ContributedCapitalMember",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Contributed Capital [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Net Income (Loss)",
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
}
}
},
"auth_ref": [
"r122",
"r123",
"r124",
"r125",
"r132",
"r133",
"r140",
"r141",
"r150",
"r152",
"r156",
"r158",
"r303"
]
},
"us-gaap_Assets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "Assets",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "TOTAL ASSETS",
"label": "Assets",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
}
}
},
"auth_ref": [
"r66",
"r73",
"r93",
"r111",
"r150",
"r153",
"r157",
"r164",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r178",
"r231",
"r235",
"r244",
"r307",
"r337",
"r338",
"r343"
]
},
"CIK0001818674_ZanderTherapeuticsInc2Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ZanderTherapeuticsInc2Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Zander Therapeutics Inc 2 [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_FairValueOfFinancialInstrumentsPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "FairValueOfFinancialInstrumentsPolicy",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
"documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
}
}
},
"auth_ref": [
"r58",
"r59"
]
},
"us-gaap_InterestIncomeExpenseNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "InterestIncomeExpenseNet",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Interest Income (Expense)",
"documentation": "The net amount of operating interest income (expense)."
}
}
},
"auth_ref": [
"r71"
]
},
"us-gaap_CommonStockSharesIssued": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CommonStockSharesIssued",
"presentation": [
"http://sybleuinc.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock, shares issued",
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
}
}
},
"auth_ref": [
"r4"
]
},
"us-gaap_OtherAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OtherAssets",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_Assets",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Other Assets",
"label": "Other Assets",
"documentation": "Amount of assets classified as other."
}
}
},
"auth_ref": [
"r65",
"r72",
"r92"
]
},
"us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 7.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase ( Decrease) in Income Tax Payable",
"documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
}
}
},
"auth_ref": [
"r28"
]
},
"us-gaap_GeneralAndAdministrativeExpenseAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "GeneralAndAdministrativeExpenseAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "General and Administrative:"
}
}
},
"auth_ref": []
},
"us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInAccountsPayableRelatedParties",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase (Decrease) in Notes Payable, Related Parties",
"documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence."
}
}
},
"auth_ref": [
"r28"
]
},
"us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails",
"http://sybleuinc.com/role/NotesPayableDetailsNarrative",
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Defined Benefit Plans Disclosures [Table]",
"documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
}
}
},
"auth_ref": [
"r51",
"r52",
"r53",
"r54",
"r55"
]
},
"us-gaap_DebtSecuritiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DebtSecuritiesCurrent",
"crdr": "debit",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Investment securities, fair value",
"documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading), classified as current."
}
}
},
"auth_ref": []
},
"dei_DocumentRegistrationStatement": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentRegistrationStatement",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Registration Statement",
"documentation": "Boolean flag that is true only for a form used as a registration statement."
}
}
},
"auth_ref": [
"r308"
]
},
"CIK0001818674_CommonStockPayableMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "CommonStockPayableMember",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock Payable [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_CommonStockValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CommonStockValue",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock ($.0001 par value) 100,000,000 shares authorized; par value $0.0001; 10,613,492 shares issued and outstanding as of September 30, 2023 and 10,613,492 shares issued and outstanding\u00a0\u00a0as of June 30, 2023",
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
}
}
},
"auth_ref": [
"r4",
"r307"
]
},
"dei_DocumentAccountingStandard": {
"xbrltype": "accountingStandardItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentAccountingStandard",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Accounting Standard",
"documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
}
}
},
"auth_ref": [
"r321"
]
},
"us-gaap_SharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "SharesOutstanding",
"presentation": [
"http://sybleuinc.com/role/StatementsOfShareholdersEquityDeficit"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Beginning balance, shares",
"periodEndLabel": "Ending balance, shares",
"label": "Shares, Outstanding",
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
}
}
},
"auth_ref": []
},
"CIK0001818674_NonEmployeeMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "NonEmployeeMember",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Non Employee [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_DebtDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "DebtDisclosureTextBlock",
"presentation": [
"http://sybleuinc.com/role/NotesPayable"
],
"lang": {
"en-us": {
"role": {
"label": "NOTES PAYABLE",
"documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
}
}
},
"auth_ref": [
"r47",
"r109",
"r179",
"r180",
"r181",
"r182",
"r183",
"r184",
"r185",
"r186",
"r188",
"r189",
"r190"
]
},
"CIK0001818674_EmployeeMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "EmployeeMember",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Employee [Member]"
}
}
},
"auth_ref": []
},
"dei_EntityInteractiveDataCurrent": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityInteractiveDataCurrent",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Interactive Data Current",
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
}
}
},
"auth_ref": [
"r324"
]
},
"us-gaap_ResearchAndDevelopmentExpensePolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ResearchAndDevelopmentExpensePolicy",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "RESEARCH AND DEVELOPMENT COSTS",
"documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
}
}
},
"auth_ref": [
"r56"
]
},
"dei_OtherReportingStandardItemNumber": {
"xbrltype": "otherReportingStandardItemNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "OtherReportingStandardItemNumber",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Other Reporting Standard Item Number",
"documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
}
}
},
"auth_ref": [
"r321"
]
},
"us-gaap_CommonStockSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CommonStockSharesOutstanding",
"presentation": [
"http://sybleuinc.com/role/BalanceSheetsParenthetical",
"http://sybleuinc.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock, Shares, Outstanding",
"verboseLabel": "Common stock, shares outstanding",
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
}
}
},
"auth_ref": [
"r4",
"r48"
]
},
"us-gaap_CommonStockSharesAuthorized": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CommonStockSharesAuthorized",
"presentation": [
"http://sybleuinc.com/role/BalanceSheetsParenthetical",
"http://sybleuinc.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock, Shares Authorized",
"verboseLabel": "Common stock, shares authorized",
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
}
}
},
"auth_ref": [
"r4"
]
},
"CIK0001818674_JoanneVainiMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "JoanneVainiMember",
"presentation": [
"http://sybleuinc.com/role/RelatedPartyTransactions.DetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Joanne Vaini [Member]"
}
}
},
"auth_ref": []
},
"dei_DocumentShellCompanyEventDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentShellCompanyEventDate",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Shell Company Event Date",
"documentation": "Date of event requiring a shell company report."
}
}
},
"auth_ref": [
"r321"
]
},
"us-gaap_PrepaidExpenseCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "PrepaidExpenseCurrent",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Prepaid Expenses",
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
}
}
},
"auth_ref": [
"r94",
"r168",
"r169",
"r300"
]
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"auth_ref": []
},
"us-gaap_EarningsPerSharePolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "EarningsPerSharePolicyTextBlock",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "BASIC EARNINGS (LOSS) PER SHARE",
"documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
}
}
},
"auth_ref": [
"r36",
"r37"
]
},
"CIK0001818674_OncologyPharmaIncMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "OncologyPharmaIncMember",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails",
"http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Oncology Pharma Inc [Member]"
}
}
},
"auth_ref": []
},
"CIK0001818674_BostoniaPartnersMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "BostoniaPartnersMember",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Bostonia Partners [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_ResearchAndDevelopmentExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ResearchAndDevelopmentExpense",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total Research and Development",
"label": "Research and Development Expense",
"documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
}
}
},
"auth_ref": [
"r56",
"r86",
"r345"
]
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
"documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
}
}
},
"auth_ref": [
"r1",
"r35",
"r41",
"r57"
]
},
"dei_AmendmentDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "AmendmentDescription",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Amendment Description",
"documentation": "Description of changes contained within amended document."
}
}
},
"auth_ref": []
},
"CIK0001818674_ZanderTherapeuticsIncMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ZanderTherapeuticsIncMember",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Zander Therapeutics Inc [Member]"
}
}
},
"auth_ref": []
},
"dei_DocumentFiscalPeriodFocus": {
"xbrltype": "fiscalPeriodItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentFiscalPeriodFocus",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Fiscal Period Focus",
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
}
}
},
"auth_ref": []
},
"CIK0001818674_ZanderBiologicsIncMember": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ZanderBiologicsIncMember",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Zander Biologics Inc [Member]"
}
}
},
"auth_ref": []
},
"dei_AnnualInformationForm": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "AnnualInformationForm",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Annual Information Form",
"documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
}
}
},
"auth_ref": [
"r322"
]
},
"us-gaap_ScheduleOfInvestmentsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ScheduleOfInvestmentsTable",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails",
"http://sybleuinc.com/role/InvestmentSecuritiesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Investments [Table]",
"documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items."
}
}
},
"auth_ref": [
"r83"
]
},
"CIK0001818674_BostoniaPartners1Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "BostoniaPartners1Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Bostonia Partners 1 [Member]"
}
}
},
"auth_ref": []
},
"dei_DocumentShellCompanyReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentShellCompanyReport",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Shell Company Report",
"documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
}
}
},
"auth_ref": [
"r321"
]
},
"dei_DocumentFiscalYearFocus": {
"xbrltype": "gYearItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentFiscalYearFocus",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Fiscal Year Focus",
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine1": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressAddressLine1",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line One",
"documentation": "Address Line 1 such as Attn, Building Name, Street Name"
}
}
},
"auth_ref": []
},
"CIK0001818674_BostoniaPartners2Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "BostoniaPartners2Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Bostonia Partners 2 [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_ResearchAndDevelopmentExpenseAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ResearchAndDevelopmentExpenseAbstract",
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"label": "Research and Development:"
}
}
},
"auth_ref": []
},
"us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "BasisOfAccountingPolicyPolicyTextBlock",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "BASIS OF ACCOUNTING",
"documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
}
}
},
"auth_ref": []
},
"dei_AuditedAnnualFinancialStatements": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "AuditedAnnualFinancialStatements",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Audited Annual Financial Statements",
"documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
}
}
},
"auth_ref": [
"r322"
]
},
"us-gaap_IncreaseDecreaseInCollateralHeldUnderSecuritiesLending": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInCollateralHeldUnderSecuritiesLending",
"crdr": "credit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 10.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Unrealized Loss (Gain) in Investment Securities",
"label": "Increase (Decrease) in Collateral Held under Securities Lending",
"documentation": "The increase (decrease) during the period in the carrying amount of assets, which may include but are not limited to cash and investments, received as collateral pertaining to securities loaned to a counterparty to the transaction. Includes the change during the period in any unrealized gain or loss on such investments."
}
}
},
"auth_ref": []
},
"CIK0001818674_BostoniaPartners3Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "BostoniaPartners3Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Bostonia Partners 3 [Member]"
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine2": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressAddressLine2",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line Two",
"documentation": "Address Line 2 such as Street or Suite number"
}
}
},
"auth_ref": []
},
"us-gaap_IncreaseDecreaseInAccruedLiabilities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IncreaseDecreaseInAccruedLiabilities",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Increase (Decrease) in Accrued Expenses",
"documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
}
}
},
"auth_ref": [
"r28"
]
},
"us-gaap_GeneralAndAdministrativeExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "GeneralAndAdministrativeExpense",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/StatementOfOperations": {
"parentTag": "us-gaap_CostsAndExpenses",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/StatementOfOperations"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total General and Administrative",
"label": "General and Administrative Expense",
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
}
}
},
"auth_ref": [
"r21"
]
},
"us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
"crdr": "credit",
"presentation": [
"http://sybleuinc.com/role/InvestmentSecuritiesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Investment securities, net unrealized gain or loss realized",
"documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
}
}
},
"auth_ref": [
"r286",
"r335"
]
},
"CIK0001818674_ZanderTherapeuticsInc1Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ZanderTherapeuticsInc1Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Zander Therapeutics Inc 1 [Member]"
}
}
},
"auth_ref": []
},
"dei_EntityAddressAddressLine3": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressAddressLine3",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line Three",
"documentation": "Address Line 3 such as an Office Park"
}
}
},
"auth_ref": []
},
"us-gaap_PrepaidExpenseNoncurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "PrepaidExpenseNoncurrent",
"crdr": "debit",
"calculation": {
"http://sybleuinc.com/role/BalanceSheets": {
"parentTag": "us-gaap_OtherAssets",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://sybleuinc.com/role/BalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Prepaid Expenses ( Long Term)",
"documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
}
}
},
"auth_ref": [
"r329"
]
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "CommonStockParOrStatedValuePerShare",
"presentation": [
"http://sybleuinc.com/role/BalanceSheetsParenthetical",
"http://sybleuinc.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock, Par or Stated Value Per Share",
"verboseLabel": "Common stock, par value",
"documentation": "Face amount or stated value per share of common stock."
}
}
},
"auth_ref": [
"r4"
]
},
"CIK0001818674_BostoniaPartners4Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "BostoniaPartners4Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Bostonia Partners 4 [Member]"
}
}
},
"auth_ref": []
},
"dei_DocumentPeriodStartDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "DocumentPeriodStartDate",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Period Start Date",
"documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
}
}
},
"auth_ref": []
},
"us-gaap_IntangibleAssetsFiniteLivedPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "IntangibleAssetsFiniteLivedPolicy",
"presentation": [
"http://sybleuinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "INTANGIBLE ASSETS",
"documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
}
}
},
"auth_ref": [
"r45",
"r265",
"r266",
"r267",
"r269",
"r301"
]
},
"dei_EntityAddressCityOrTown": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2022",
"localname": "EntityAddressCityOrTown",
"presentation": [
"http://sybleuinc.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, City or Town",
"documentation": "Name of the City or Town"
}
}
},
"auth_ref": []
},
"CIK0001818674_ZanderBiologicsInc1Member": {
"xbrltype": "domainItemType",
"nsuri": "http://sybleuinc.com/20230930",
"localname": "ZanderBiologicsInc1Member",
"presentation": [
"http://sybleuinc.com/role/NotesPayableDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Zander Biologics Inc 1 [Member]"
}
}
},
"auth_ref": []
},
"us-gaap_ScheduleOfInvestmentsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2022",
"localname": "ScheduleOfInvestmentsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Schedule of Investments [Abstract]"
}
}
},
"auth_ref": []
}
}
}
},
"std_ref": {
"r0": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "205",
"SubTopic": "40",
"URI": "https://asc.fasb.org/subtopic&trid=51888271"
},
"r1": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "205",
"URI": "https://asc.fasb.org/topic&trid=2122149"
},
"r2": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(22))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r3": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(28))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r4": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(29))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r5": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r6": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r7": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r8": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(31))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r9": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(32))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r10": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.19,20)",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r11": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.19-26)",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r12": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.20)",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r13": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.21)",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r14": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.22(a)(1))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r15": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.22)",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r16": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.29-31)",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r17": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(10))",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r18": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(20))",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r19": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03)",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r20": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.3)",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r21": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.4)",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r22": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.4,6)",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r23": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.6)",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r24": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.9)",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r25": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "14",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
},
"r26": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "24",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
},
"r27": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "25",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
},
"r28": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "28",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
},
"r29": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "28",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
},
"r30": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "28",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
},
"r31": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "4",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
},
"r32": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
},
"r33": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
},
"r34": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "8",
"URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
},
"r35": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"URI": "https://asc.fasb.org/topic&trid=2122369"
},
"r36": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r37": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
},
"r38": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
},
"r39": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "8",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r40": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "9",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r41": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"URI": "https://asc.fasb.org/topic&trid=2134479"
},
"r42": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "310",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SAB Topic 4.E)",
"URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
},
"r43": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "350",
"SubTopic": "30",
"Section": "45",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
},
"r44": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "350",
"SubTopic": "30",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(2)",
"URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r45": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "350",
"SubTopic": "30",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r46": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "350",
"SubTopic": "30",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(2)",
"URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r47": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"URI": "https://asc.fasb.org/topic&trid=2208564"
},
"r48": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
},
"r49": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.3-04)",
"URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r50": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"URI": "https://asc.fasb.org/topic&trid=2208762"
},
"r51": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
},
"r52": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
},
"r53": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "3",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
},
"r54": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "4",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
},
"r55": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "55",
"Paragraph": "17",
"URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
},
"r56": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "730",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
},
"r57": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"URI": "https://asc.fasb.org/topic&trid=2197479"
},
"r58": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "820",
"SubTopic": "10",
"Section": "60",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
},
"r59": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "825",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
},
"r60": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "230",
"Section": "45",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
},
"r61": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "835",
"SubTopic": "30",
"Section": "45",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
},
"r62": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r63": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r64": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "940",
"SubTopic": "20",
"Section": "25",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
},
"r65": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(10))",
"URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
},
"r66": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(11))",
"URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
},
"r67": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(16))",
"URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
},
"r68": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(23))",
"URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
},
"r69": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04(15))",
"URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r70": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04(22))",
"URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r71": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04.10)",
"URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r72": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(10))",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r73": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(12))",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r74": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(16))",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r75": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r76": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(25))",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r77": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03.1(h))",
"URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
},
"r78": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(18))",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r79": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(8))",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r80": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04.7)",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r81": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "220",
"Section": "45",
"Paragraph": "3",
"Subparagraph": "(k)",
"URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
},
"r82": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
"URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
},
"r83": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "320",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-12)",
"URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
},
"r84": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "320",
"Section": "S99",
"Paragraph": "5",
"Subparagraph": "(SX 210.12-13)",
"URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
},
"r85": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "320",
"Section": "S99",
"Paragraph": "6",
"Subparagraph": "(SX 210.12-14)",
"URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
},
"r86": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "985",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
},
"r87": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "105",
"SubTopic": "10",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
},
"r88": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "105",
"SubTopic": "10",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(f)",
"URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
},
"r89": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "205",
"SubTopic": "20",
"Section": "50",
"Paragraph": "7",
"URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r90": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "45",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r91": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "45",
"Paragraph": "5",
"URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
},
"r92": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(17))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r93": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(18))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r94": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(7))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r95": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(9))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r96": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.22(a)(2))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r97": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "45",
"Paragraph": "1A",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
},
"r98": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "45",
"Paragraph": "1B",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
},
"r99": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
},
"r100": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
},
"r101": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "50",
"Paragraph": "5",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
},
"r102": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "50",
"Paragraph": "6",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
},
"r103": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(1))",
"URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
},
"r104": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "17",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
},
"r105": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
},
"r106": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "24",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
},
"r107": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(e)",
"URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
},
"r108": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
},
"r109": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(c))",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r110": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(e)(1))",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r111": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r112": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(h))",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r113": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "45",
"Paragraph": "23",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
},
"r114": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "45",
"Paragraph": "24",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
},
"r115": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "45",
"Paragraph": "5",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
},
"r116": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r117": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(1)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r118": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(2)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r119": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(3)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r120": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(4)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r121": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)(1)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r122": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "11",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r123": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "11",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r124": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
},
"r125": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
},
"r126": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
},
"r127": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "8",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
},
"r128": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "50",
"Paragraph": "9",
"URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
},
"r129": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "5",
"Subparagraph": "(SAB Topic 11.M.Q2)",
"URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
},
"r130": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "6",
"URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
},
"r131": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"URI": "https://asc.fasb.org/topic&trid=2122394"
},
"r132": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "10",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
},
"r133": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "11",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
},
"r134": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "16",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
},
"r135": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "40",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r136": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "40",
"Subparagraph": "(b)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r137": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "40",
"Subparagraph": "(b)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r138": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "40",
"Subparagraph": "(b)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
},
"r139": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "60B",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
},
"r140": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "45",
"Paragraph": "60B",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
},
"r141": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r142": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "272",
"SubTopic": "10",
"Section": "45",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
},
"r143": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r144": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r145": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "11",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r146": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "12",
"URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r147": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "22",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r148": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "22",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r149": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "22",
"Subparagraph": "(h)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r150": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "22",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
},
"r151": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r152": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r153": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r154": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r155": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r156": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r157": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r158": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(f)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
},
"r159": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "40",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
},
"r160": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "41",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
},
"r161": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "42",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
},
"r162": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "310",
"SubTopic": "20",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(d)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
},
"r163": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "310",
"SubTopic": "20",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(d)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
},
"r164": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "323",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r165": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "326",
"SubTopic": "10",
"Section": "65",
"Paragraph": "4",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r166": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "326",
"SubTopic": "10",
"Section": "65",
"Paragraph": "4",
"Subparagraph": "(e)(1)",
"URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r167": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "326",
"SubTopic": "10",
"Section": "65",
"Paragraph": "4",
"Subparagraph": "(e)(2)",
"URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r168": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "340",
"SubTopic": "10",
"Section": "05",
"Paragraph": "5",
"URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
},
"r169": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "340",
"SubTopic": "10",
"Section": "45",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
},
"r170": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(i))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r171": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r172": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iv))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r173": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(5))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r174": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(i))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r175": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r176": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r177": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iv))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r178": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(5))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
},
"r179": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1B",
"Subparagraph": "(g)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r180": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1B",
"Subparagraph": "(h)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r181": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1B",
"Subparagraph": "(i)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r182": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1B",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r183": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1C",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
},
"r184": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1C",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
},
"r185": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1C",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
},
"r186": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1E",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
},
"r187": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1F",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
},
"r188": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1I",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
},
"r189": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1I",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
},
"r190": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1I",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
},
"r191": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r192": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(g)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r193": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(h)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r194": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(i)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r195": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "13",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
},
"r196": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "14",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
},
"r197": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "14",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
},
"r198": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "14",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
},
"r199": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "16",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
},
"r200": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "18",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
},
"r201": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "18",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
},
"r202": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "18",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
},
"r203": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.3-04)",
"URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r204": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(n)",
"URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
},
"r205": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r206": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(1)",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r207": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r208": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(i)",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r209": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(ii)",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r210": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(v)",
"URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
},
"r211": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "65",
"Paragraph": "15",
"Subparagraph": "(e)",
"URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
},
"r212": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "65",
"Paragraph": "15",
"Subparagraph": "(f)(1)",
"URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
},
"r213": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "65",
"Paragraph": "15",
"Subparagraph": "(f)(2)",
"URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
},
"r214": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 14.D.2.Q6)",
"URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
},
"r215": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "718",
"URI": "https://asc.fasb.org/topic&trid=2228938"
},
"r216": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "45",
"Paragraph": "25",
"URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
},
"r217": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "45",
"Paragraph": "28",
"URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
},
"r218": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "10",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
},
"r219": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "17",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
},
"r220": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "19",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
},
"r221": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "20",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
},
"r222": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "9",
"URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
},
"r223": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(d)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r224": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(d)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r225": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(e)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r226": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(e)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r227": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(e)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
},
"r228": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB TOPIC 6.I.7)",
"URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
},
"r229": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "20",
"Section": "45",
"Paragraph": "2",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
},
"r230": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "45",
"Paragraph": "19",
"URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
},
"r231": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r232": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r233": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1A",
"Subparagraph": "(a)(1)",
"URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r234": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1A",
"Subparagraph": "(c)(1)",
"URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r235": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(bb)",
"URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r236": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r237": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
},
"r238": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r239": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r240": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(f)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r241": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(c)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
},
"r242": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(c)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
},
"r243": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(c)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
},
"r244": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "825",
"SubTopic": "10",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(f)",
"URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
},
"r245": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "825",
"SubTopic": "10",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(e)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
},
"r246": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "825",
"SubTopic": "10",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(e)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
},
"r247": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "825",
"SubTopic": "10",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(e)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
},
"r248": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "30",
"Section": "45",
"Paragraph": "17",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
},
"r249": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "30",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r250": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "30",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r251": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "30",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r252": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "30",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r253": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "830",
"SubTopic": "30",
"Section": "50",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r254": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "842",
"SubTopic": "10",
"Section": "65",
"Paragraph": "5",
"Subparagraph": "(f)(1)",
"URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
},
"r255": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "842",
"SubTopic": "10",
"Section": "65",
"Paragraph": "5",
"Subparagraph": "(f)(3)",
"URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
},
"r256": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "848",
"SubTopic": "10",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(1)",
"URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
},
"r257": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "848",
"SubTopic": "10",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(a)(3)(iii)(03)",
"URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
},
"r258": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "848",
"SubTopic": "10",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
},
"r259": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r260": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r261": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r262": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r263": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "6",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
},
"r264": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"URI": "https://asc.fasb.org/topic&trid=2122745"
},
"r265": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "920",
"SubTopic": "350",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
},
"r266": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "920",
"SubTopic": "350",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
},
"r267": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "920",
"SubTopic": "350",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
},
"r268": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "924",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 11.L)",
"URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
},
"r269": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "926",
"SubTopic": "20",
"Section": "50",
"Paragraph": "5",
"URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
},
"r270": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "926",
"SubTopic": "20",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(1)",
"URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
},
"r271": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "926",
"SubTopic": "20",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(2)",
"URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
},
"r272": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "926",
"SubTopic": "20",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(3)",
"URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
},
"r273": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "15",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
},
"r274": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "15",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
},
"r275": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "20",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
},
"r276": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "20",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
},
"r277": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
},
"r278": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
},
"r279": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "33",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
},
"r280": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "33",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
},
"r281": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "35A",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
},
"r282": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "35A",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
},
"r283": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "8",
"Subparagraph": "(c)(1)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
},
"r284": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "932",
"SubTopic": "235",
"Section": "50",
"Paragraph": "8",
"Subparagraph": "(c)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
},
"r285": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "235",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-05(b)(2))",
"URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
},
"r286": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(3)(d))",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r287": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "220",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(9))",
"URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r288": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(e)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r289": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(1)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r290": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(2)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r291": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(2)(i)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r292": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(2)(ii)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r293": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(2)(iii)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r294": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(2)(iv)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r295": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "944",
"SubTopic": "40",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(h)(2)",
"URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r296": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "210",
"Section": "45",
"Paragraph": "20",
"URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
},
"r297": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "210",
"Section": "45",
"Paragraph": "21",
"URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
},
"r298": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "320",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.12-12B)",
"URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
},
"r299": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "946",
"SubTopic": "320",
"Section": "S99",
"Paragraph": "5D",
"Subparagraph": "(SX 210.12-13D)",
"URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
},
"r300": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "45",
"Paragraph": "1",
"Subparagraph": "(g)",
"URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r301": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
},
"r302": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
},
"r303": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "280",
"SubTopic": "10",
"Section": "50",
"Paragraph": "31",
"URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
},
"r304": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1B",
"Subparagraph": "(d)",
"URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
},
"r305": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "55",
"Paragraph": "4J",
"URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
},
"r306": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "55",
"Paragraph": "4K",
"URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
},
"r307": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "852",
"SubTopic": "10",
"Section": "55",
"Paragraph": "10",
"URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
},
"r308": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12"
},
"r309": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b"
},
"r310": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-2"
},
"r311": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-23"
},
"r312": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "d1-1"
},
"r313": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "g"
},
"r314": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12, 13, 15d"
},
"r315": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "13e",
"Subsection": "4c"
},
"r316": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "14d",
"Subsection": "2b"
},
"r317": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "15",
"Subsection": "d"
},
"r318": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Section": "14a",
"Number": "240",
"Subsection": "12"
},
"r319": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-K",
"Number": "249",
"Section": "310"
},
"r320": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-Q",
"Number": "240",
"Section": "308",
"Subsection": "a"
},
"r321": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Number": "249",
"Section": "220",
"Subsection": "f"
},
"r322": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Number": "249",
"Section": "240",
"Subsection": "f"
},
"r323": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Section": "13",
"Subsection": "a-1"
},
"r324": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-T",
"Number": "232",
"Section": "405"
},
"r325": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "405"
},
"r326": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "425"
},
"r327": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "7A",
"Section": "B",
"Subsection": "2"
},
"r328": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(1))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r329": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(17))",
"URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r330": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "50",
"Paragraph": "6",
"URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
},
"r331": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "235",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r332": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "45",
"Paragraph": "23",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
},
"r333": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "45",
"Paragraph": "24",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
},
"r334": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "250",
"SubTopic": "10",
"Section": "45",
"Paragraph": "5",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
},
"r335": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "321",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
},
"r336": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "323",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r337": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(ii))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r338": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "470",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iii))",
"URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
},
"r339": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "40",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(3)",
"URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
},
"r340": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "820",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(bbb)(2)",
"URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
},
"r341": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "825",
"SubTopic": "10",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(f)",
"URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
},
"r342": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r343": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "852",
"SubTopic": "10",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(a)",
"URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r344": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "852",
"SubTopic": "10",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(b)",
"URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r345": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Publisher": "FASB",
"Name": "Accounting Standards Codification",
"Topic": "912",
"SubTopic": "730",
"Section": "25",
"Paragraph": "1",
"URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
}
}
}